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Abstract
Klebsiella pneumoniae is recognized as an urgent threat to human health due to the increas-
ing isolation of multidrug resistant strains. Hypervirulent strains are a major concern due to
their ability to cause life-threating infections in healthy hosts. The type VI secretion system
(T6SS) is widely implicated in microbial antagonism, and it mediates interactions with host
eukaryotic cells in some cases. In silico search for genes orthologous to T6SS component
genes and T6SS effector genes across 700 K. pneumoniae genomes shows extensive diver-
sity in T6SS genes across the K. pneumoniae species. Temperature, oxygen tension, pH,
osmolarity, iron levels, and NaCl regulate the expression of the T6SS encoded by a hypervir-
ulent K. pneumoniae strain. Polymyxins and human defensin 3 also increase the activity of
the T6SS. A screen for regulators governing T6SS uncover the correlation between the tran-
scription of the T6SS and the ability to kill E. coli prey. Whereas H-NS represses the T6SS,
PhoPQ, PmrAB, Hfq, Fur, RpoS and RpoN positively regulate the T6SS. K. pneumoniae
T6SS mediates intra and inter species bacterial competition. This antagonism is only evident
when the prey possesses an active T6SS. The PhoPQ two component system governs the
activation of K. pneumoniae T6SS in bacterial competitions. Mechanistically, PhoQ periplas-
mic domain, and the acid patch within, is essential to activate K. pneumoniae T6SS. Klebsi-
ella T6SS also mediates anti-fungal competition. We have delineated the contribution of
each of the individual VgrGs in microbial competition and identified VgrG4 as a T6SS effec-
tor. The DUF2345 domain of VgrG4 is sufficient to intoxicate bacteria and yeast. ROS gener-
ation mediates the antibacterial effects of VgrG4, and the antitoxin Sel1E protects against the
toxic activity of VgrG4. Our findings provide a better understanding of the regulation of the
T6SS in bacterial competitions, and place ROS as an early event in microbial competition.
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Author summary
Klebsiella pneumoniae has been singled out as an “urgent threat to human health” due to
extremely drug resistant strains. Numerous studies investigate the molecular mechanisms
underlying antibiotic resistance in K. pneumoniae, while others dissect the virulence strat-
egies of this pathogen. However, there is still limited knowledge on the fitness of Klebsiella
in the environment, and, particularly, the competition of Klebsiella with other species.
Here, we demonstrate that Klebsiella exploits the type VI secretion system (T6SS) nano-
weapon to kill bacterial competitors and fungi. K. pneumoniae perceives T6SS attacks
from bacterial competitors, resulting in retaliation against the aggressive cell. The percep-
tion of the attack involved the sensor PhoPQ and led to the up-regulation of the T6SS. We
identified one of the toxins deployed by the T6SS to antagonize other microbes and
revealed how Klebsiella protects itself from this toxin. Our findings provide a better
understanding of the T6SS role in microbial competition and uncover new aspects on
how bacteria regulate T6SS-mediated microbial antagonism.
Introduction
The type VI secretion system (T6SS) is a bacterial nanomachinery that delivers substrates into a
target cell in a one-step process. The system was first described as a cluster of impaired nitrogen
fixation (imp) genes in Rhizobium leguminosarum [1]. Shortly after, Rao and co-workers identi-
fied the T6SS of Edwardsiella tarda in a mass spectrometric screen for secreted virulence factors
[2]. Initial studies reported that T6SSs contributed to virulence and/or interaction with eukaryotic
cells in multiple bacterial species, primarily pathogens (Vibrio cholerae, Burkholderia ssp., Pseudo-
monas aeruginosa, E. tarda, Salmonella gallinarum) [3–6]. However, substantial experimental
data argue for its broad significance in bacterial fitness in the environment. The first antibacterial
T6SS was described in P. aeruginosa in 2010 [7], and since then the T6SS has been implicated in
efficient killing of competitors, quorum sensing and horizontal gene transfer [8–11].
T6SS are encoded within clusters which all contain 13 conserved core genes named tssA-M
encoding the proteins making up the basic secretion apparatus [12–15]. ClpV/TssH is a cyto-
plasmic AAA+ ATPase allowing recycling of the T6SS machinery. Additional copies of essen-
tial core components, tssD/hcp and tssI/vgrG, can be found outside the main T6SS cluster and
are often associated with genes encoding putative effector proteins. Bioinformatics and struc-
tural evidence sustain the notion that the T6SS apparatus is closely related to components of a
contractile bacteriophage forming a cell puncture device [12–15]. The T6SS inner tube is com-
posed of hexamers of Hcp, and it is believed that VgrG sits at the top of the Hcp tube. PAAR
domain containing proteins have been shown to bind the distal end of VgrG to complete the
tip of the machinery but also to act as a platform for recruitment of effectors [16]. The evidence
indicates that an effector can either be fused to a homologue of one of the components of the
Hcp-VgrG-PAAR structure as an additional domain, or can interact non-covalently with one
of the components of this structure [17]. The first characterized effector domain was the C-ter-
minal actin cross-linking domain of the VgrG-1 protein secreted by the T6SS of V. cholerae
[18]. Many other effectors are encoded in proximity to vgrG, hcp or paar genes strongly sug-
gesting that their secretion is associated with the neighbouring core component; this has been
extensively investigated in the case of Serratia marcescens and P. aeruginosa.
Klebsiella pneumoniae has been singled out as an “urgent threat to human health” by the
World Health Organization due to extremely drug resistant strains. More than a third of the
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K. pneumoniae isolates reported to the European Centre for Disease Prevention and Control
were resistant to at least one antimicrobial group, the most common resistance phenotype
being the combined resistance to fluoroquinolones, third-generation cephalosporins and ami-
noglycosides. Numerous studies investigate the molecular mechanisms underlying antibiotic
resistance in K. pneumoniae, while others dissect the virulence strategies of this pathogen
[19,20]. However, there is still limited knowledge on the fitness of Klebsiella in the environ-
ment, and, particularly, the competition of Klebsiella with other species. In this context, a first
analysis of four Klebsiella genomes revealed that this pathogen may encode a T6SS with the 13
core T6SS genes organized in two syntenic segments [21].Three putative VgrGs and two Hcp
were described as potential effector proteins through their sequence similarities to V. cholerae
and P. aeruginosa effector proteins [21]. Our recent comparative genomics study indicates that
the T6SS is part of the Klebsiella core genome [22], and two different phospholipases, PLD1
and Tle1, have been identified as T6SS effectors [22,23].
In the present study, we characterize the T6SS encoded by a hypervirulent K. pneunomiae
strain and investigate its role in intra and inter bacterial species, and anti-fungal competition.
Our findings demonstrate that interaction with competing bacteria expressing T6SS triggers
the activation of the PhoPQ two-component system leading to increased transcription of the
T6SS and killing of competitor bacteria. Moreover, polymyxins, last line antibiotic against
multidrug Klebsiella infections, and human defensins also induce T6SS-dependent killing in a
PhoPQ dependent manner. In this work, we also identify the antibacterial effector domain
fused to VgrG4 and demonstrate that its toxicity is through the generation of reactive oxygen
species (ROS), highlighting the role of ROS in antibacterial competition.
Results
Organization of the T6SS gene clusters in K. pneumoniae CIP52.145
Strain K. pneumoniae CIP52.145 (hereafter Kp52145) belongs to the K. pneumoniae KpI group
which includes the vast majority of strains associated with human infection, including numer-
ous multidrug-resistant and hypervirulent clones [24]. Kp52145 encodes all virulence func-
tions significantly associated with invasive community-acquired disease in humans [22,24].
Kp52145 possess three T6SS loci (Fig 1A). Locus I encodes all of the known conserved core
genes encoding the proteins making up the basic secretion apparatus, including ClpV/TssH,
Hcp1/TssD1, and VgrG1/TssI1, except TssE. A putative effector is found downstream of
vgrG1. In the Kp52145 genome available, hcp1, vgrG1, tssM3 are annotated as pseudogenes.
However, real time PCR analysis revealed full length transcripts of the anticpated size (159 bp
for hcp1, 1190 bp for vgrG1, and 1596 bp for tssM3). Moreover, as the results of this manu-
script show, we detected proteins of the expected size for Hcp1 and VgrG1. Locus II is incom-
plete, hcp, clpV, vipA/tssB, vipB/tssC are missing and there is an insertion in sciN/tssJ (Fig 1A).
However, it does contain another vgrG, which we termed vgrG2, and three putative effectors,
locus tag BN49_0937, BN49_0942, BN49_0943, the latter one containing a characteristic
PAAR domain. Two putative immunity proteins, locus tag BN49_0941 and BN49_0936, are
also found in this cluster. As we have recently described [22], locus III is also incomplete and
contains an insertion of nine proteins including another vgrG, which we termed vgrG4, a
PLD1 effector, and a PAAR protein. We have recently demonstrated that pld1 encodes a viru-
lence factor essential in the pneumonia mouse model [22]. There are no reported studies of
the function of the proteins encoded by the five genes containing sel-1 repeats in K. pneumo-
niae, although in Legionella pneumophila similar Sel1 containing proteins have been impli-
cated in interactions with host cells [25]. In silico analysis of the Kp52145 genome revealed
the presence of three additional putative hcp genes, locus tag BN49_1035, BN49_2747 and
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BN49_2887, and a cluster of five genes, locus tag BN49_4908 to BN49_4913, encoding four
putative effectors and a PAAR protein (Fig 1B).
Diversity of T6SS locus in K. pneumoniae
We sought to investigate the diversity of the T6SS locus in different K. pneumoniae strains. Ini-
tially, we focused on strains ATCC43816, widely used in virulence studies, NTUH-K2044 and
SGH10, isolates of the clonal group CG23 causing liver abscesses [26,27], NJST258_1, isolate
of the clonal group ST258 [28], and strain MGH78578, the first K. pneumoniae multidrug
resistant isolate sequenced. To analyse these genomes we used the integrated database SecReT6
(http://db-mml.sjtu.edu.cn/SecReT6/). Locus I is conserved in all strains, and it contains the
conserved genes known to be essential to build a T6SS (S1 Fig). vgrG1 is found in all strains in
locus I. Notably, there is a significant diversity in the number of effectors and immunity pro-
teins present in this locus, and every strain analysed has a different repertoire. In all strains,
locus II is also incomplete, and this locus is also characterized by the presence of a vgrG. Like-
wise Kp52145, MGH75878, encodes vgrG2 in this locus whereas ATCC431816 and
NTUH-K2044 encode vgrG4, and SGH10 and NJST258_1 encode a new vgrG, which we
termed vgrG3. Each of the strains analysed encode also different repertoire of putative effectors
in this locus. Only ATCC43816 and MGH75878 present a third T6SS locus, being different to
that encoded by Kp52145. Collectively these findings demonstrate that locus I encodes a com-
plete T6SS although there is considerable genome diversity in terms of effectors, vgrGs, and
number of T6SS loci.
To obtain a global picture of the T6SS in K. pneumoniae, we downloaded 700 K. pneumo-
niae genomes from NCBI, selected to represent the broad phylogenetic structure of the species.
Using the SecRet6 database we searched for genes orthologous to T6SS component genes (Fig
2A) and T6SS effector genes (Fig 2B) across the genome data set. Our analysis shows extensive
Fig 1. Predicted T6SS gene loci K. pneumoniae CIP52.145. (A) Analysis of the three loci encoding the T6SS. Locus I encodes the known conserved core genes,
whereas loci II and III are incomplete. Each loci is characterized by a distinct vgrG and a different set of putative effector(s) and immunity proteins. (B) Additional T6SS
related genes found elsewhere in the genome. In both panels the colour code of the genes indicate putative structural genes, hcp, vgrG, effector (denoted as Kpe for K.
pneumoniae effectors), immunity protein (denoted as Kpi for K. pneumoniae immunity protein), regulator, and PAAR-domain containing protein.
https://doi.org/10.1371/journal.ppat.1007969.g001
PLOS PATHOGENS Klebsiella pneumoniae T6SS for antimicrobial warfare
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007969 March 19, 2020 4 / 54
Fig 2. Diversity of K. pneumoniae T6SS. Diversity of T6SS component (A) and effector (B) genes across 500 K. pneumoniae genomes. Each horizontal block
represents an individual gene present in the SecRet6 database. Presence of the gene at greater than 80% nucleotide diversity is represented by a blue block. Absence,
indicated by lack of an orthologous gene sequence at greater than 25% nucleotide identity is presented by a red block. Orthologous sequences at a nucleotide identity
between 25% and 80% are represented by yellow blocks.
https://doi.org/10.1371/journal.ppat.1007969.g002
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diversity in T6SS genes across the K. pneumoniae species, with most of this diversity exhibited
as high levels of sequence dissimilarity rather than loss of genes. This diversity is independent
of population structure which is indicative of frequent and extensive recombination in the
Klebsiella T6SS locus, analogous to that observed in capsule encoding regions [29]. To deter-
mine the potential diversity present in the key vgrG1 gene, we created a pangenome of the
downloaded genomes and blasted all ~65,000 genes for orthologous sequences of the vgrG1
gene of Kp52145. Our analysis identified 33 different orthologous vgrG1 genes within the pan-
genome, suggesting that extensive T6SS diversity occurs at all levels from component genes
through to the essential-for-function vgrG1.
Kp52145 does not outcompete Escherichia coli in a T6SS-dependent
manner in Lysogeny broth
The T6SS of different pathogens has been shown to mediate killing of other bacteria. To deter-
mine whether Kp52145 exhibits T6SS-mediated antibacterial activity, we used strain E. coli
MG1655 harbouring a plasmid conferring resistance to apramycin as prey in bacterial killing
assays (Table 1). Co-incubation of E coli with Kp52145 showed no difference in killing of E.
coli, while a dramatic reduction was observed when E. coli was incubated with S. marcescens
Db10 (S2 Fig). In an attempt to understand the lack of antibacterial effect of Kp52145 T6SS,
we hypothesized that the K. pneumoniae capsule polysaccharide (CPS) interferes with the con-
tact-dependent killing. We then tested the cps-deficient strain 52145-ΔmanC for killing of E.
coli. However, the cps mutant did not kill E. coli in these conditions, suggesting that the pres-
ence of CPS does not interfere with T6SS-dependent killing.
Environmental signals affecting K. pneumoniae T6SS expression
To explain the lack of T6SS-dependent killing of Kp52145 when bacteria are grown in lysogeny
broth (LB) we speculated that the expression of Kp52145 T6SS is regulated by environmental
signals in the hope of identifying conditions in which the system could be up-regulated. To
investigate the T6SS transcriptional pattern, we constructed one reporter strain carrying non-
disruptive chromosomal transcriptional fusion containing a promoterless luciferase firelfly
gene (lucFF) under the control of the promoter region of the first gene of the T6SS gene locus
I, tssB::lucFF. We focused on locus I because this is the conserved one in Klebsiella strains, and
it encodes essential components known to be necessary to assemble a T6SS. We first investi-
gated whether growth phase may affect the pattern of expression of the tssB::lucFF fusion. The
highest levels of luciferase activity were observed when the reporter strain reached mid-expo-
nential phase (S3A Fig). Therefore, luciferase activity was measured at mid-exponential phase
in subsequent experiments testing different environmental conditions. We next tested the
impact of temperature, pH, oxygen tension, osmolarity and ionic strength, and iron levels on
the expression of the transcriptional fusion. Results are shown as heat-map indicating when
the luciferase activity peaked (Fig 3A). Full data set is uploaded in a public repository (EBI
Biostudies, accession number S-BSST301). Experiments examining the impact of temperature
established that luciferase activity was higher at 37˚C than at 20˚C (Fig 3A), and, therefore, the
subsequent experiments testing other conditions were performed growing the reporter strain
at 37˚C. K. pneumoniae survives over a wide range of pH (pH 4.0 to 10.0). Luciferase activity
was assayed in cultures grown in different buffered media inoculated in parallel. In the range
of pH tested, luciferase activity peaked at pH 6.0 (Fig 3A). To get an indication whether T6SS
expression might be regulated in response to oxygen tension, we assessed the effect of aeration
using 5-ml cultures grown under the following conditions of increasing aeration: in a 15-ml
tube incubated vertically shaking at 180 rpm (condition 1), in a 15-ml slanted tube (45o)
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Table 1. Strains and plasmids used in this study.
Bacterial strain or plasmid Genotype or comments Source or reference(s)
Esherichia coli
C600 F– [e14– (McrA–) or e14+ (McrA+)] thr-1 leuB6 thi-1 lacY1 glnV44 rfbD1 fhuA21 Laboratory stock
GT115 F -mcrAΔ(mrr-hsdRMS-mcrBC) 80ΔlacZΔM15 ΔlacX74 recA1rpsL (StrA) endA1Δdcm uidA
(ΔMluI):: pir-116 ΔsbcC-sbcD
InvivoGen
β2163 (F-) RP4-2-Tc::Mu ΔdapA::(erm-pir) [KmREmR ] [82]
MG1655 Wild type K12 MG1655; ilvG rfb-50 rph-1 Laboratory stock
Yeast species
Saccharomyces cerevisiae YPH499 MATa ade 2–101 trp1-63 leu2-1 ura3-52 his3-200 lys2-801 [94]
Saccharomyces cerevisiae IGC2608 National collection
yeast cultures
Candida albicans ATCC18804 ATCC
Klebsiella pneumoniae
CIP52.145 Clinical isolate; serotype O1:K2; sequence type ST66, Kp52145 [95]
NJST258-1 Clinical isolate; serotype O1:K2; sequence type ST258 [28]
NJST258-2 Clinical isolate; serotype O1:K2; sequence type ST258 [28]
MGH78578 (ATCC700721)Clinical isolate; serotype O1:K2; sequence type ST38 ATCC
NTUH-K2044 Clinical isolate; serotype O1:K2; sequence type ST23 [27]
ATCC43816 Clinical isolate; serotype O1:K2; sequence type ST493 ATCC
52145-Δhfq Kp52145, Δhfq; hfq gene was inactivated To be published
52145-ΔrpoN Kp52145, ΔrpoN; rpoN gene was inactivated To be published
52145-ΔrpoS Kp52145, ΔrpoS; rpoS was inactivated To be published
52145-ΔpmrAB Kp52145, ΔpmrAB; RifR; the pmrAB genes were inactivated [32]
52145-ΔmanC Kp52145, ΔmanC; manC gene was inactivated [31]
52145-Δfur Kp52145, Δfur; fur gene was inactivated To be published
52145-ΔphoQGB Kp52145, ΔphoQ::Km-GenBlock; RifR KmR; the phoQ gene was inactivated [32]
52145-Δhns Kp52145, Δhns; h-ns gene was inactivated To be published
52145-ΔrcsB Kp52145, ΔrcsB; the rcsB gene was inactivated [32]
52145-ΔrcsB-ΔphoQGB 52145-ΔrcsB, ΔphoQ::Km-GenBlock; RifR KmR; the phoQ and rcsB genes were inactivated [32]
52145-ΔmgrB Kp52145, ΔmgrB; mgrB gene was inactivated [31]
52145-ΔmgrB-ΔphoQGB Kp52145, ΔmgrB, ΔphoQ::KM-GenBlock; the mgrB and phoQ genes were inactivated; KmR [31]
52145-ΔphoQGBCom Kp52145 ΔphoQ::Km-GenBlock CmR, KmR; Tn7-Cm_KpnPhoPQCom was integrated into the att
Tn7 site
[32]
52145-ΔphoQGBComFLAG Kp52145 ΔphoQ::Km-GenBlock Cmr, Kmr; Tn7-Cm_ PhoPQwt_FLAG was integrated into the
att Tn7 site
This study
52145-ΔphoQGBComPhoQ45-190 Kp52145 ΔphoQ::Km-GenBlock Cmr, Kmr; Tn7-Cm_ PhoPQ45-190_FLAG was integrated into
the att Tn7 site
This study
52145-ΔphoQGBComPhoQGNNNNAQ Kp52145 ΔphoQ::Km-GenBlock Cmr, Kmr; Tn7-Cm_ PhoPQGNNNNAQ_FLAG was integrated
into the att Tn7 site
This study
52145-ΔvgrG1 Kp52145, ΔvgrG1; vgrG1 gene was inactivated This study
52145-ΔvgrG2 Kp52145, ΔvgrG2; vgrG2 gene was inactivated This study
52145-ΔvgrG4 Kp52145, ΔvgrG4; vgrG4 gene was inactivated This study
52145-ΔvgrG2-ΔvgrG4 Kp52145, ΔvgrG2, ΔvgrG4; vgrG2 and vgrG4 genes, were inactivated This study
52145-ΔvgrG2-ΔvgrG1 Kp52145, ΔvgrG2, ΔvgrG1; vgrG2 and vgrG1 genes, were inactivated This study
52145-ΔvgrG1-ΔvgrG4 Kp52145, ΔvgrG1, ΔvgrG4; vgrG1 and vgrG4 genes, were inactivated This study
52145-ΔvgrG2-ΔvgrG1-ΔvgrG4 Kp52145, ΔvgrG2, ΔvgrG4, ΔvgrG1; vgrG2, vgrG4 and vgrG1 genes, were inactivated This study
52145-ΔclpV Kp52145, ΔclpV; clpV gene of T6SS cluster I was inactivated This study
52145-ΔtssB Kp52145, ΔtssB; tssB gene of T6SS cluster I was inactivated This study
43816-ΔtssB ATCC43816, ΔtssB; tssB gene of T6SS cluster II was inactivated This study
NTUH-ΔtssB NTUH-K2044, ΔtssB; tssB gene of T6SS cluster II was inactivated This study
(Continued)
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Table 1. (Continued)
Bacterial strain or plasmid Genotype or comments Source or reference(s)
Acinetobacter baumannii
DSM30011 DSM30011 Wild type strain [96]
DSM30011 ΔtssM DSM30011 isogenic derivative tssM deletion mutant, marked with an apramycin resistance
cassette
[96]
Ab17978T6+ Ab17978 lacking pAB3, S/T sensitive, T6SS active [37]
Ab17978T6+ΔtssM Ab17978 lacking pAB3, S/T sensitive, T6SS active, tssM mutant [37]
Bulkholderia cenocepacia
K56-2 ET12 clone related to J2315, CF clinical isolate BCRRCa; [97]
K56-2 ΔatsRΔt6SS JST144; K56-2 derivative with ΔatsR, ΔbcsJ (hcp; BCAL0343), and ΔamrABC
(BCAL1674–1676), defective in T6SS
[98]
Serratia marcescens
Db10 Wild type strain, nonpigmented. [99,100]
Plasmids
pGEM-T Easy Cloning plasmid; AmpR Promega
pGPI-SceI-2 Suicide vector, R6K origin of replication, Mob+, carries a I-SceI endonuclease site; TmpR [81]
pDAI-SceI-SacB Expresses the I-SceI endonuclease, sacB gene; TetR [81]
pGPL01 Firefly luciferase (lucFF) transcriptional fusion suicide vector, R6K origin of replication; AmpR [101]
pMMB207 Cloning plasmid, IPTG inducible promoter, CmR [102]
pBAD30 pACYC184/p15A Origin of Replication, expression construct; AmpR [103]
pUC18R6KT7mini-Cm A derivative of the pUC18R6K-mini-Tn7T-Gm vector [104]
pSTNSK-Tp pTSNSK-Tp containing a transposase for Tn7 insertion; KmR, TmpR [84]
pGPLKpnPhoP pGPL01 containing the phoP promoter region; AmpR [32]
pGPLKpnProTssB pGPL01 containing the Kp52.145 T6SS locus I promoter region; AmpR This study
pGPLKpnProTssK2 pGPL01 containing the Kp52.145 T6SS locus II promoter region; AmpR This study
pGPLKpnProSciZ3 pGPL01 containing the Kp52.145 T6SS locus III promoter region; AmpR This study
pGEMTApra pGEM-T Easy plasmid containing an apramycin resistance casette; ApraR This study
pGEMTΔvgrG1 pGEM-T Easy plasmid containing the vgrG1 deletion construct; AmpR This study
pGEMTΔvgrG2 pGEM-T Easy plasmid containing the vgrG2 deletion construct; AmpR This study
pGEMTΔvgrG4 pGEM-T Easy plasmid containing the vgrG4 deletion construct; AmpR This study
pGEMTΔtssB pGEM-T Easy plasmid containing the tssB deletion construct for T6SS locus I; AmpR This study
pGEMTΔclpV pGEM-T Easy plasmid containing the clpV deletion construct for T6SS locus I; AmpR This study
pGEMT43ΔtssL pGEM-T Easy plasmid containing the tssB deletion construct for ATCC43816 strain; AmpR This study
pGEMTNTUHΔtssB pGEM-T Easy plasmid containing the tssB deletion construct for T6SS locus II; AmpR This study
pGPI-SceI-2-ΔvgrG1 pGPI-SceI-2 plasmid containing the vgrG1 deletion construct; TmpR This study
pGPI-SceI-2-ΔvgrG2 pGPI-SceI-2 plasmid containing the vgrG2 deletion construct; TmpR This study
pGPI-SceI-2—ΔvgrG4 pGPI-SceI-2 plasmid containing the vgrG4 deletion construct; TmpR This study
pGPI-SceI-2-ΔtssB pGPI-SceI-2 plasmid containing the tssB deletion construct for T6SS locus I; TmpR This study
pGPI-SceI-2-ΔclpV pGPI-SceI-2 plasmid containing the clpV deletion construct for T6SS locus I; TmpR This study
pGPI-SceI-2-43ΔtssB pGPI-SceI-2 plasmid containing the tssB deletion construct for T6SS locus II; TmpR This study
pGPI-SceI-2-NTUHΔtssB pGPI-SceI-2 plasmid containing the tssB deletion construct for T6SS locus II; TmpR This study
pBADVgrG1 pBAD30 plasmid containing gene coding for the Kp52.145 T6SS protein vgrG1; AmpR This study
pBADVgrG1603-750 pBAD30 plasmid containing VgrG1 amino acids 603–750; Amp
R This study
pBADVgrG2 pBAD30 plasmid containing gene coding for the Kp52.145 T6SS protein vgrG2; AmpR This study
pBADVgrG4 pBAD39 plasmid containing gene coding for the Kp52.145 T6SS protein vgrG4; AmpR This study
pBADVgrG41-517 pBAD30 plasmid containing VgrG4 amino acids 1–517; Amp
R This study
pBADVgrG4570-899 pBAD30 plasmid containing VgrG4 amino acids 570–899; Amp
R This study
pBADVgrG4612-759 pBAD30 plasmid containing VgrG4 amino acids 612–759; Amp
R This study
(Continued)
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shaking at 180 rpm (condition 2), in a 25-ml tube incubated vertically shaking at 180 rpm
(condition 3), and in a 30-ml tube incubated vertically shaking at 180 rpm (condition 4) (Fig
3A). Vigorous aeration significantly reduced the luciferase levels compared to the 5-ml stand-
ing tube (condition 1), in which the oxygen tension is probably low (Fig 3A). Iron restriction
conditions were achieved by growing the reporter strain in medium with increasing concen-
trations of the iron chelator 2–2’ bipyridyl. Luciferase levels peaked when bacteria were grown
with the highest concentration of the iron chelator (Fig 3A), suggesting that low iron concen-
trations up-regulate the expression of the locus I of the T6SS. The effects of ionic strength ver-
sus osmolarity were tested in LB with increasing concentrations of salt (0 to 595 mM KCl) or
rhamnose and sucrose. The levels of luciferase activity decreased similarly with increasing con-
centrations of the solutes, supporting that high osmolarity down-regulates the expression of
this T6SS locus (Fig 3A). However, high levels of NaCl did not have an inhibitory effect, and,
in fact, we observed a significant increase in the luciferase activity when bacteria were grown
in LB containing 595 mM NaCl (Fig 3A), suggesting that the environment signal triggered by
NaCl is the sodium concentration.
To investigate the transcriptional pattern of the other two T6SS loci, we constructed two
additional reporter strains in which lucFF was under the control of the promoter regions of
Table 1. (Continued)
Bacterial strain or plasmid Genotype or comments Source or reference(s)
pBADVgrG1FLAG pBAD30 plasmid containing vgrG1 with a FLAG tag; AmpR This study
pBADVgrG1603-750FLAG pBAD30 plasmid containing vgrG1603-750 with a FLAG tag; AmpR This study
pBADVgrG2FLAG pBAD30 plasmid containing vgrG2 with a FLAG tag; AmpR This study
pBADVgrG4FLAG pBAD30 plasmid containing vgrG4 with a FLAG tag; AmpR This study
pBADVgrG4612-759FLAG pBAD30 plasmid containing vgrG4612-759 with a FLAG tag; AmpR This study
pBADVgrG41-517VSV pBAD30 plasmid containing vgrG4612-759 with a VSV-G tag; AmpR This study
pBADVgrG4570-899VSV pBAD30 plasmid containing vgrG4570-899 with a VSV-G tag; AmpR This study
pBADClpV pBAD30 plasmid containing gene coding for the Kp52.145 T6SS protein clpV; AmpR This study
pMMBSel1D pMMB207 containing sel1D; CmR This study
pMMBSel1E pMMB207 containing sel1E; CmR This study
pJT04-mCherry pJT04 encoding the mCherry red flouresecent protein; AmpR, TetR Miguel Valvano
pBADHcp1VSV pBAD30 plasmid containing hcp1 with a VSV-G tag; AmpR This study
pEG(KG) To expresses GST fusions in yeast [93]
pEG(KG)VgrG1 pEG(KG) containing vgrG1 This study
pEG(KG)VgrG2 pEG(KG) containing vgrG2 This study
pEG(KG)VgrG4 pEG(KG) containing vgrG4 This study
pGEMTPhoPQwt_FLAG pGEM-T Easy containing the promoter and genes of phoP and phoQ; phoQ has a C terminal
FLAG tag
This study
pGEMTPhoPphoQ45-190 _FLAG pGEM-T Easy containing the promoter and genes of phoP and phoQ; phoQ has a C terminal
FLAG tag and the periplasmic region between 45–190 aminoacids is deleted, AmpR
This Study
pGEMTPhoPphoQGNNNNAQ _FLAG pGEM-T Easy containing the promoter and genes of phoP and phoQ; phoQ has a C terminal
FLAG tag and the acidic patch EQGDDSE has been mutated to GNNNNAQ; AmpR
This Study





pUC18R6KT7mini-Cm containing the promoter and genes of phoP and phoQ; phoQ has a C




pUC18R6KT7mini-Cm containing the promoter and genes of phoP and phoQ; phoQ has a C
terminal FLAG tag and the acidic patch EQGDDSE has been mutated to GNNNNAQ
This Study
a. Burkholderia cenocepacia research and referral repository for Canadian CF Clinics
https://doi.org/10.1371/journal.ppat.1007969.t001
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Fig 3. Regulation of K. pneumoniae T6SS. (A) Heat-map analysis of the luciferase levels of the transcriptional fusion
tssB::lucFF in the background of the wild-type strain grown until exponential phase at different temperatures (Temp);
pH (LB was buffered as follows: 100 mM MES pH 5.5 and 6, HEPES pH7, MOPS pH8), oxygen tension (1, 15-ml tube
incubated vertically shaking at 180 rpm; 2, 15-ml slanted tube (45o) shaking at 180 rpm; 3, 25-ml tube incubated
vertically shaking at 180 rpm; 4, 30-ml tube incubated vertically shaking at 180 rpm), and different concentrations of
KCl, rhamnose, sucrose, NaCl and the iron chelator 2–2’ bipyridyl. (B, C) Bacterial killing mediated by Kp52145,
52145-ΔclpV (ΔclpV), 52145-ΔclpV complemented with pBADClpV (ΔclpV/pBADClpV) against E. coli MG1655.
Induction of the pBAD ara promoter with arabinose (0.1%) is indicated. After 6 h incubation in LBpH6, and LBNaCl
bacteria were recovered, diluted in PBS 0 to 10−5 and spotted in LB agar plate. The data are presented as means ± the
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tssK2 and sciZ3 encoded in locus II and locus III, respectively (Fig 1). The expression of both
fusions was also higher in the exponential phase of growth (S3 Fig). The expression of sciZ3::
lucFF followed similar pattern than that of tssB;;lucFF, whereas the expression of tssK2::lucFF
was not upregulated by iron restriction, ionic strength and osmolarity (S4 Fig). Full data set is
uploaded in a public repository (EBI Biostudies, accession number S-BSST301).
Of all the conditions tested, the highest luciferase levels of the tssB::lucFF fusion were
observed when Kp52145 was grown in LB buffered to pH 6 (LBpH6), and in LB containing 595
mM NaCl (LBNaCl). Therefore, we sought to determine whether Kp52145 may exhibit T6SS-
mediated antibacterial activity in these conditions. Kp52145 killed E. coli when Klebsiella was
grown in LBpH6 (Fig 3B) and LBNaCl (Fig 3C), the latter condition being in which less E. coli
was recovered. However, this was not the case when E. coli was co-incubated with Kp52145
clpV mutant (Fig 3B and 3C). Complementation of the clpV mutant restored the killing of E.
coli prey, indicating that Kp52145-triggered E. coli killing is T6SS dependent (Fig 3B and 3C).
We did not observe any difference in E. coli recovery when co-incubated with either the wild
type or the cps mutant (S5 Fig), reinforcing the notion that K. pneumoniae CPS does not inter-
fere with T6SS-dependent killing.
To further confirm that Kp52145 T6SS is active when bacteria are grown in LBpH6 and
LBNaCl, we assessed the presence of Hcp in culture supernatants. The secretion of Hcp is con-
sidered an indicator of a functional T6SS [18,30]. The Hcp1 (locus tag BN49_2467, encoded in
the locus I) was fused to a VSV-G tag at the C terminus and cloned into pBAD30 to give
pBADHcp1. The plasmid was transferred to the wild-type strain, and the tssB mutant, and
Hcp1 levels were assessed by immunoblotting after induction of the ara promoter of pBAD
with arabinose. Immunoblotting experiments using anti-VSV-G antibodies showed that Hcp1
was expressed in the cytosol of both strains. However Hcp1 was only detected in the superna-
tants of the wild-type strain grown in LBpH6 and LBNaCl (Fig 3D), further confirming that the
T6SS is functional and secretes Hcp, a hallmark T6SS protein, when Kp52145 is grown in
LBpH6 and LBNaCl.
Regulatory networks controlling K. pneumoniae T6SS expression
To further characterize the regulation of Kp52145 T6SS, we sought to identify regulators con-
trolling the expression of the T6SS when Klebsiella is grown under different conditions. We
focused on the regulation of locus I since our previous results showed that the expression pat-
tern of this locus correlates with the function of the T6SS using as read-outs antibacterial com-
petition and Hcp1 secretion. The tssB::lucFF transcriptional fusion was introduced into phoQ,
mgrB, rcsB, h-ns, fur, hfq, rpoS, rpoN, and pmrAB mutants, and the amount of light deter-
mined. When the reporter strains were grown in LB, the expression of tssB::lucFF was signifi-
cantly higher in the h-ns, mgrB and rcsB mutant backgrounds than in the wild-type one (Fig
4A). In contrast, the activity of the transcriptional fusion was lower in the phoQ, pmrAB, hfq,
fur, rpoS, and rpoN backgrounds than in the wild-type one (Fig 4A). As anticipated, E. coli was
not killed when co-incubated with rpoN, rpoS, hfq, fur and pmrAB mutants (Fig 4B). However,
the increased expression of the fusion in the h-ns, mgrB and rcsB mutant backgrounds resulted
in increased activity of the T6SS because co-incubation of the h-ns, mgrB and rcsB mutants
standard deviations (n = 3). #, P< 0.0001, n.s., (P> 0.05) not significantly different from the results for mock-treated
bacteria; one-way ANOVA Bonferroni correction for multiple comparisons. (D) Western blot analysis using an anti-
VSV-G antibody demonstrating the presence of Hcp1 (16 kDa) in the supernatants and cell pellets of K. pneumoniae
CIP52.145 (WT), and 52145-ΔtssB (ΔtssB) grown in LB, LBpH6, and LBNaCl. Membranes were reprobed wih antibody
anti RNA Polymerase α. Image is representative of three independent experiments.
https://doi.org/10.1371/journal.ppat.1007969.g003
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Fig 4. Screen of transcriptional factors controlling K. pneumoniae T6SS expression. (A) Analysis of the T6SS expression by Kp52145, 52145-
Δhfq (hfq), 52145-ΔphoPQGB (phoPQ), 52145-ΔpmrAB (pmrAB), 52145-Δfur (fur), 52145-Δhn-s (hn-s), 52145-ΔrpoS (rpoS), 52145-ΔrpoN
(rpoN), 52145-ΔmgrB (mgrB), 52145-ΔmgrB-ΔphoPQGB (mgrB-phoPQ), 52145-ΔrcsB (rcsB), and 52145-ΔrcsB-ΔphoPQGB (rcsB-phoPQ) carrying
the transcriptional fusion tssB::lucFF and grown in LB. Luminescence is expressed as relative light units (RLU). The data are presented as
means ± the standard deviations (n = 3). �#, results are significantly different (P< 0.0001 [two-tailed t test]) from the results for Kp52145; ���,
results are significantly different (P< 0.001 [two-tailed t test]) from the results for Kp52145. (B) Bacterial killing activity mediated by Kp52145,
52145-Δhfq (hfq), 52145-ΔphoPQGB (phoPQ), 52145-ΔpmrAB (pmrAB), 52145-Δfur (fur), 52145-Δhn-s (hn-s), 52145-ΔrpoS (rpoS), 52145-ΔrpoN
(rpoN), 52145-ΔmgrB (mgrB), 52145-ΔmgrB-ΔphoPQGB (mgrB-phoPQ), 52145-ΔrcsB (rcsB), and 52145-ΔrcsB-ΔphoPQGB (rcsB-phoPQ) against
E. coli MG1655. Mock, PBS-treated E. coli. Number of recovered target cells following 6 h incubation in LB is indicated. The data are presented as
means ± the standard deviations (n = 3). ���, results are significantly different (P< 0.001 [two-tailed t test]) from the results for Kp52145.
https://doi.org/10.1371/journal.ppat.1007969.g004
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with E. coli in LB resulted in a significant reduction in E. coli survival (Fig 4B). The fact that
studies from our laboratory have demonstrated that phoPQ expression is up regulated in the
mgrB and rcsB mutant backgrounds [31,32] suggests that the up-regulation of tssB::lucFF in
the mgrB and rcsB backgrounds was due to up-regulation of phoPQ. Supporting this hypothe-
sis, the activity of the transcriptional fusion was downregulated in the double mutants mgrB-
phoQ and rcsB-phoQ backgrounds (Fig 4A), and E. coli was not killed when co-incubated with
the double mutants mgrB-phoQ and rcsB-phoQ (Fig 4B).
The expression of the fusion tssB::lucFF in the different strains’ backgrounds was also
assessed growing the reporter strains in LBpH6 and LBNaCl. Neither in LBpH6 nor in LBNaCl we
observed the up-regulation of the fusion in any mutant background (S6A Fig and S6B Fig). In
contrast, the activity of the fusion was significantly down-regulated in the phoQ, pmrAB, hfq,
fur, rpoS, and rpoN mutant backgrounds in both media (S6A Fig and S6B Fig). As expected,
the phoQ, pmrAB, hfq, fur, rpoS, and rpoN mutants did not kill E. coli when grown in either
LBpH6 or LBNaCl. (S6C Fig and S6D Fig). The activity of the tssB::lucFF fusion was downregu-
lated in the h-ns mutant background only in LBpH6 (S6A Fig), and this result correlated with a
lack of killing of the E. coli prey in LBpH6 (S6C Fig).
Collectively, these findings uncovered the correlation between the transcription of the T6SS
and the ability to kill E. coli. Whereas H-NS repressed the T6SS in LB, PhoPQ, PmrAB, Hfq,
Fur, RpoS and RpoN positively regulated the T6SS in all the conditions tested.
Expression and activity of K. pneumoniae T6SS is enhanced by
antimicrobial peptides
Polymyxin B and E (colistin) are antimicrobial peptides used as the “last-line” antibiotics
against multidrug resistant K. pneumoniae infections. We and others have reported that chal-
lenging Klebsiella with polymyxins induces transcriptional changes affecting the pathogen
pathophysiology [32–34]. We sought to establish whether incubation of Kp52145 with sub
lethal concentrations of polymyxins will affect the activity of the T6SS. Incubation of Kp52145
with sub lethal concentrations of either polymyxin B or colistin resulted in a significant
decrease of E. coli recovery in LB (Fig 5A). When the experiments were performed testing
Kp52145 clpV mutant, we did not detect any decrease in the recovery of E. coli, indicating that
the observed inhibition is T6SS-dependent (Fig 5A). These findings prompted us to investigate
whether other antimicrobial peptides will also increase the activity of Kp52145 T6SS. We tested
human β-defensin 3 (HBD3) because the levels of this peptide increase several fold during
human pneumonia [35]. A sub lethal concentration of HBD3 also triggered a significant
decrease in the recovery of E. coli when co-cultured with Kp51245 but not when the clpV
mutant was tested (Fig 5B), indicating that the increased Kp52145-mediated killing is T6SS-
dependent.
Based on the knowledge that antimicrobial peptides activate the PhoPQ system [36] and
that PhoPQ controls the expression of Kp52145 T6SS, we asked whether antimicrobial pep-
tides upregulate the expression of the Kp52145 T6SS in a PhoPQ-dependent manner. As we
expected, sub lethal concentrations of polymyxins and HBD3 increased the activity of the
phoP::lucFF fusion (Fig 5C). The luciferase activity of the tssB fusion was up regulated by poly-
myxins and HBD3 in a PhoPQ-dependent manner because the antimicrobial peptides did not
trigger the upregulation of the transcriptional fusion in the phoQ mutant background (Fig
5D–5F). Complementation of the phoQ mutant restored luciferase levels (Fig 5D–5F). Alto-
gether, these results suggest that antimicrobial peptides activate the PhoPQ two-component
system which, in turn, positively regulates Kp52145 T6SS resulting in increased T6SS-depen-
dent antimicrobial activity. Therefore, we hypothesized that antimicrobial peptides-induced
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Fig 5. Antimicrobial peptides enhanced the expression and activity of K. pneumoniae T6SS. (A, B) Sub lethal concentrations of
polymyxin B (0.1 μg/ml), colistin (0.1 μg/ml), and human β-defenisn 3 (0.1 μg/ml) increase T6SS-dependent bacterial antagonism. Kp52145,
52145-ΔclpV (ΔclpV), 52145-ΔphoPQGB (ΔphoPQ), and 52145-ΔphoPQGBCom (ΔphoPQ::phoPQ) were incubated with the peptides for 90
min before, co-incubation with E. coli MG1655 prey in LB agar plates supplemented with the peptides for 6 h. Control experiments showed
that incubation of E. coli with these sub lethal concentrations did not affect its recovery in the absence of predator bacteria. Number of
recovered target cells in LB is indicated. The data are presented as means ± the standard deviations (n = 3). #, P< 0.0001, n.s. (P> 0.05), not
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T6SS-dependent killing should be abrogated in the phoQ mutant background. Indeed, this was
the case (Fig 5A and 5B). Complementation of the phoQ mutant restored the killing potential
of the phoQ mutant to wild-type levels (Fig 5A and 5B).
K. pneumoniae T6SS mediates intra and inter species bacterial competition
in a PhoPQ-controlled manner
To establish whether Kp52145 T6SS possess the capacity to mediate intra species antagonism,
we tested whether Kp52145 exerts antibacterial activity against K. pneumoniae strains
ATCC43816, and NTUH-K2044 in a T6SS-dependent manner. Quantitative competition
assays revealed that Kp52145 killed both K. pneumoniae strains (Fig 6A and S7A Fig). How-
ever, this was not the case when the Klebsiella prey strains were co-incubated with the
Kp52145 clpV mutant (Fig 6A and S7A Fig), indicating that Kp52145-triggered killing of kin is
T6SS-mediated. Similar experiments were carried to investigate whether Kp52145 T6SS medi-
ates inter species competition. We found that Kp52145 reduced populations of Acinetobacter
baumannii strains ATCC17978 and DSM3001 (Fig 6B and S7B Fig) and Burkholderia cenoce-
pacia K56-2 (Fig 6C) in a T6SS-dependent manner. Complementation restored the killing abil-
ity of the clpV mutant (Fig 6A–6C). For these experiments, A. baumannii ATCC17978 was
cured of plasmid pAB3 that suppresses the T6SS activity of this strain [37].
Interestingly, Kp52145 T6SS-triggered killing of Klebsiella, Acinetobacter and Burkholderia
was observed in LB, condition in which we have shown Kp52145 did not exert T6SS-mediated
antibacterial activity against E. coli prey. Previous studies in P. aeruginosa demonstrated that
T6SS-depending killing is stimulated by T6SS activity occurring in the prey species [38]. Con-
trol experiments confirmed that K. pneumoniae strains ATCC43816 and NTUH-K2044, and
A. baumannii and B. cenocepacia killed E. coli prey using their T6SS under our assay condi-
tions (S8 Fig), uncovering the functional activity of their T6SS. When Kp52145 was co-incu-
bated with any of the T6SS mutants of the K. pneumoniae strains, A. baumannii strains and B.
cenocepacia there was no reduction in the recovery of the prey (Fig 6D–6F, S7C Fig, S7D Fig).
These results suggested that co-cultivation of K. pneumoniae with organisms possessing an
active T6SS leads to an increased activity of the T6SS. To further investigate this hypothesis,
we assessed the activity of the tssB::lucFF transcriptional fusion when Kp52145 was co-incu-
bated with K. pneumoniae ATCC43816 and NTUH-K2044, A. baumannii ATCC17978 and
DSM3001 and B. cenocepacia K56-2 wild-type and T6SS mutant strains. Co-incubation with
any of the wild-type strains resulted in a significant increase in the luciferase levels (Fig 7A–
7C). In contrast, tssB::lucFF activity was not significantly different when Kp52145 was co-incu-
bated with any of the T6SS mutants or with no bacteria (Fig 7A–7C), confirming that incuba-
tion with a prey with an active T6SS results in up-regulation of K. pneumoniae T6SS.
We have previously demonstrated that PhoPQ activation results in up-regulation of
Kp52145 T6SS. Therefore, we sought to determine whether co-incubation with prey with an
active T6SS may up-regulate phoPQ expression. To investigate this question, we determined
significant differences from the results for PBS-treated (mock) E. coli; one-way ANOVA Bonferroni correction for multiple comparisons.
(C) Expression of phoPQ by Kp52145 carrying the transcriptional fusion phoP::lucFF after incubation with sub lethal concentrations of
polymyxin B (PxB, 0.1 μg/ml) and colistin (Col, 0.1 μg/ml), and human β-defenisn 3 (HBD3, 0.1 μg/ml) for 90 min. Luminescence is
expressed as relative light units (RLU). The data are presented as means ± the standard deviations (n = 3). #, results are significantly different
(P< 0.0001 [two-tailed t test]) from the results for PBS-treated (mock) Kp52145. (D, E, F) Expression of T6SS by Kp52145, 52145-
ΔphoPQGB (ΔphoPQ), and 52145-ΔphoPQGBCom (ΔphoPQ::phoPQ) carrying the transcriptional fusion tssB::lucFF after incubation with
sub lethal concentrations of polymyxin B (PxB, 0.1 μg/ml) and colistin (Col, 0.1 μg/ml), and human β-defenisn 3 (HBD3, 0.1 μg/ml) for 90
min. Luminescence is expressed as relative light units (RLU). The data are presented as means ± the standard deviations (n = 3). #, results
are significantly different (P< 0.0001 [two-tailed t test]) from the results for PBS-treated Kp52145 (mock), and the indicated comparisons.
https://doi.org/10.1371/journal.ppat.1007969.g005
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the activity of the phoP::lucFF transcriptional fusion when Kp52145 was co-incubated with the
different preys. Indeed, luciferase activity of the phoP fusion was up-regulated when Kp52145
was co-incubated with preys with an active T6SS (Fig 7D–7F). In contrast, we observed no up-
regulation of the fusion when Kp52145 was incubated with any of the T6SS mutants (Fig 7D–
7F). To connect PhoPQ up-regulation with that of Kp52145 T6SS, we assessed whether co-
incubation with a prey with an active T6SS will up-regulate tssB::lucFF activity in the phoQ
mutant background. As we anticipated, co-incubation of the phoQ mutant with any of the
wild-type strains of Klebsiella (S9A Fig), Acinetobacter (S9B Fig) and Burkholderia (S9C Fig)
did not result in an increase in the tssB activity. In fact, the luciferase levels were down regu-
lated in the phoQ mutant background (S9 Fig), further confirming the role of PhoPQ to regu-
late T6SS expression. Complementation of the phoQ mutant restored luciferase levels (S9 Fig).
In good agreement with these findings showing that co-incubation of the prey with the phoQ
mutant did not upregulate the expression of tssB::lucFF fusion, the phoQ mutant did not kill
any of the Klebsiella, Acinetobacter and Burkholderia wild-type strains (Fig 6A–6C, S7A Fig
and S7B Fig). Complementation restored the killing ability of the phoQ mutant (Fig 6A–6C,
S7A Fig and S7B Fig).
Altogether, these findings demonstrate that K. pneumoniae T6SS mediates intra and inter
species bacterial competition. Remarkably, this antagonism of competitors is only evident
when the prey possess an active T6SS. The PhoPQ two component system governs the activa-
tion of K. pneumoniae T6SS in bacterial competitions.
The periplasmic domain of PhoQ is needed for the regulation of the T6SS
Studies have previously shown that the PhoQ periplasmic domain senses acid pH, divalent cat-
ions and antimicrobial peptides, and a patch of acid residues within this periplasmic sensor
domain senses divalent cations and antimicrobial peptides [39]. Given that PhoPQ controls
the regulation of the T6SS upon contact with prey with an active T6SS, we sought to determine
whether the PhoQ periplasmic domain senses the attack of prey with an active T6SS. To
address this question, the C-terminus of PhoQ was tagged with a FLAG epitope, and the con-
struct cloned into pGP-Tn7-Cm to give pGP-Tn7-CmphoPQFLAG to complement Kp52145
phoQ mutant. PhoQ-FLAG tagged restored the luciferase activity of the tssB::lucFF transcrip-
tional fusion upon incubation of the phoQ mutant with the T6SS active preys K. pneumoniae
ATCC43817 (Fig 8A), and A. baumannii ATCC17978 (Fig 8B). In contrast, complementation
of the phoQ mutant with a construct in which phoQ lacked the periplasmic domain, phoQ45-
190, did not restore luciferase levels (Fig 8A and 8B). Furthermore, complementation with a
phoQ in which the acid patch (EQGDDSE) within the periplasmic domain was mutated to
(GNNNNAQ), phoQGNNNNAQ, did not result in upregulation of the tssB::lucFF transcriptional
fusion upon incubation of the phoQ mutant with the T6SS active preys (Fig 8A and 8B). The
luciferase activity of the tssB fusion was not up regulated by colistin when the phoQ mutant
was complemented with either the phoQ lacking the periplasmic domain or the mutated acidic
Fig 6. K. pneumoniae T6SS-dependent intra and inter species bacterial competition. (A, B, C) T6SS-dependent anti-
bacterial activity as determined by recovery of target organisms K. pneumoniae ATCC43816 (Kp43816), A. baumannii
ATCC17978 (17978), and B. cenocepacia K56-2 (K56-2) following incubation with Kp52145, 52145-ΔclpV (ΔclpV), 52145-
ΔclpV complemented with pBADClpV (ΔclpV/pBADClpV), 52145-ΔphoPQGB (ΔphoPQ), and 52145-ΔphoPQGBCom
(ΔphoPQ::phoPQ). Induction of the pBAD ara promoter with arabinose (0.1%) is indicated. (D, E, F) T6SS-dependent
anti-bacterial activity as determined by recovery of target T6SS mutants 43816-ΔtssB, 17978- ΔtssM, and K56-2-Δhcp
following incubation with Kp52145. In all panels, the data are presented as means ± the standard deviations (n = 3). #,
P< 0.0001, n.s. (P> 0.05), not significant differences from the results for PBS-treated (mock) target cell; one-way
ANOVA Bonferroni correction for multiple comparisons.; one-way ANOVA Bonferroni correction for multiple
comparisons.
https://doi.org/10.1371/journal.ppat.1007969.g006
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patch (S10A Fig). The PhoPQ-controlled up regulation of the tssB::lucFF transcriptional fusion
when Klebsiella was grown in LBpH6 and LBNaCl was not observed in any of the phoQ variants
(S10B Fig). In good agreement with our previous results demonstrating that the PhoPQ system
controls the activation of the T6SS in bacterial competitions, only the PhoQ-FLAG tagged
recovered the reduction of K. pneumoniae ATCC43817, A. baumannii ATCC17978 preys
upon co-incubation with phoQ mutant (Fig 8C and 8D). Complementation with phoQ45-190
and phoQGNNNNAQ did not restore Kp52145 T6SS-mediated killing of the T6SS active preys
(Fig 8C and 8D). Western blot analysis confirmed that the PhoQ FLAG tagged proteins were
expressed by Kp52145 although the levels of PhoQ45-190 were lower than those of PhoQ and
PhoQGNNNNAQ, (S10C Fig).
Collectively, these findings revealed that the PhoQ periplasmic domain, and the acid patch
within, is essential to activate K. pneumoniae T6SS upon incubation with T6SS active competi-
tors, and by the last-line antibiotic colistin.
Contribution of K. pneumoniae VgrGs to bacterial killing
Our bioinformatic analysis revealed that Kp52145 encodes three VgrGs, making it relevant to
investigate the relative contribution of each of them to bacterial killing under different conditions.
We constructed single vgrG mutants, double mutants lacking two vgrGs, and a triple mutant lack-
ing all vgrGs, and Kp52145-mediated T6SS killing was assessed. Quantitative killing assays using
E. coli as a prey revealed that when E. coli was incubated with the vgrG1 mutant there was no kill-
ing of the prey when strains were grown in either LBpH6 or LBNaCl (S11A Fig and S11B Fig). Com-
plementation of the vgrG1 mutant restored Kp52145-triggered E. coli killing (S11A Fig and S11B
Fig). Interestingly, co-incubation of E. coli with vgrG2 or vgrG4 single mutants resulted in an
increase of E. coli recovery when bacteria were grown in LBpH6 and LBNaCl, respectively (S11A Fig
and S11B Fig). Complementation of the mutants restored Klebsiella-mediated killing of E. coli
(S11A Fig and S11B Fig). When E. coli was incubated with any double mutant lacking vgrG1, we
did not observe any reduction in E. coli population in any growth condition (S11A Fig and S11B
Fig). Co-culture of E. coli with the double mutant vgrG2-vgrG4 also resulted in no decrease in bac-
terial recovery in any growth condition (S11A Fig and S11B Fig). As anticipated, the triple mutant
did not kill E. coli in any growth condition (S11A Fig and S11B Fig). VgrG1 and VgrG4 also
mediated the increased activity of the T6SS upon incubation with sub lethal concentrations of
colistin as observed by an increase in the recovery of E. coli when co-cultured with vgrG1 and
vgrG4 single mutants (S11C Fig). Complementation of the mutants restored wild-type-triggered
killing (S11C Fig). We observed no differences in the recovery of E. coli when co-cultured with
either Kp52145 or the vgrG2 mutant (S11C Fig). Altogether, these results suggest that VgrG1
plays an essential role in Klebsiella-mediated killing whereas VgrG2 and VgrG4 contribute to
T6SS-dependent killing depending on the growth conditions.
We next sought to determine the relative contribution of each VgrG in inter, and intra bac-
terial species killing. Co-culture of the vgrG1 mutant with K. pneumoniae ATCC43816 (Fig
Fig 7. T6SS active preys activate K. pneumoniae T6SS and phoPQ. (A, B, C) Expression of T6SS by Kp52145 carrying the
transcriptional fusion tssB::lucFF after co-incubation with K. pneumoniae ATCC43816 (Kp43816), 43816-ΔtssB (ΔtssB), K.
pneumoniae NTUH-K20144 (NTUH), NTUH-ΔtssB (ΔtssB), A. baumannii ATCC17978 (17978), 17978- ΔtssM, A. baumannii
DSM30011 (DSM), DSM-ΔtssM, B. cenocepacia K56-2 (K56-2), and K56-2-ΔatsRΔT6SS (ΔatsRΔT6SS). (D, E, F) Expression of
phoPQ by Kp52145 carrying the transcriptional fusion phoP::lucFF after co-incubation with K. pneumoniae ATCC43816
(Kp43816), 43816-ΔtssB (ΔtssB), K. pneumoniae NTUH-K20144 (NTUH), NTUH-ΔtssB (ΔtssB), A. baumannii ATCC17978
(17978), 17978- ΔtssM, A. baumannii DSM30011 (DSM), DSM-ΔtssM, B. cenocepacia K56-2 (K56-2), and K56-2-ΔatsRΔT6SS
(ΔatsRΔT6SS). In all panels, luminescence is expressed as relative light units (RLU) per CFU (x109). The data are presented as
means ± the standard deviations (n = 3). #, P< 0.0001; ���, P<0.001; ��, P< 0.01; n.s. not significant (P> 0.05) from the
results for mock-treated Kp52145 (mock); one-way ANOVA Bonferroni correction for multiple comparisons.
https://doi.org/10.1371/journal.ppat.1007969.g007
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9A), A. baumannii ATCC17978 (Fig 9B), and B. cenocepacia K56-2 (Fig 9C) resulted in no kill-
ing of any the preys. Interestingly, we observed no increase in the recovery of any of the preys
when co-incubated with the vgrG2 mutant. In contrast, co-incubation of the preys with vrgG4
mutant resulted in an increase in the recovery of Klebsiella (Fig 9A), Acinetobacter (Fig 9B)
and Burkholderia (Fig 9C). Complementation of vgrG1 and vgrG4 mutants restored
Kp52145-dependent killing of the preys (Fig 9A–9C), demonstrating that Kp52145 T6SS-
dependent intra and inter species bacterial competition is dependent on VgrG1 and VgrG4.
K. pneumoniae T6SS mediates fungal competitions
To determine whether Kp52145 T6SS also mediates antifungal competition, we co-incubated
Kp52145 with the clinically important fungal pathogen Candida albicans and the model yeast
Saccharomyces cerevisiae. Co-culture of Kp52145 with both organisms resulted in a significant
decrease in the recovery of yeast and fungal cells (Fig 10A and 10B). When the experiments
were performed using the Klebsiella clpV mutant the recovery of Saccharomyces and Candida
was not affected (Fig 10A and 10B). Complementation restored the killing ability of the clpV
mutant, confirming that Kp52145-induced killing of the two yeast species is T6SS-dependent
(Fig 10A and 10B).
We then investigated which of the VgrGs may play a role in Kp52145-dependent antifungal
activity. Quantitative killing assays revealed an increase in C. albicans recovery when co-cul-
tured with either vgrG2 or vgrG4 mutants (Fig 10A). Complementation of these mutants
resulted in a decrease in the recovery of cell growth of C. albicans (Fig 10A), demonstrating
that VgrG2 and VgrG4 are necessary for Kp52145-induced killing of C. albicans. VgrG4 was
also necessary for Kp52145-mediated killing of S. cerevisiae because we observed an increase
in the recovery of yeast when co-cultured with the vgrG4 mutant (Fig 10B). In contrast, no
increase in recovery was observed when S. cerevisiae was co-incubated with either vgrG1 or
vgrG2 mutants. Collectively, these findings highlight a role for VgrG4 in Klebsiella T6SS-medi-
ated intoxication of fungal cells.
K. pneumoniae T6SS mutants are attenuated in the Galleria mellonella
infection model
The G. mellonella infection model is well established to assess the virulence of K. pneumoniae
[40]. Moreover, there is a good correlation between the virulence in G. mellonella and the
mouse model [40]. To investigate whether the Kp52145 T6SS is necessary for the virulence of
K. pneumoniae in G. mellonella, equal CFUs of Kp52145 and T6SS mutants were injected into
G. mellonella and survival of the larvae was monitored over several days. Inoculation with ster-
ile PBS into the larvae resulted in no mortality (Fig 11A). 90% of the larvae infected with 106
CFUs of the clpV and tssB1 mutants survived after 120 h. In contrast, only 15% of the larvae
challenged with 106 CFUs of Kp52145 survived (Fig 11A). Infection with ATCC43816 and
Fig 8. The periplasmic domain of PhoQ is needed for the regulation of the T6SS. (A, B) Expression of T6SS by Kp52145, 52145-
ΔphoPQGB (ΔphoPQ), 52145-ΔphoQGBComFLAG (ΔphoPQ::phoPQFLAG), 52145-ΔphoQGBComPhoQ45-190 (ΔphoPQ::phoPQ45-190), and
52145-ΔphoQGBComPhoQGNNNNAQ (ΔphoPQ::phoPQGNNNNAQ) carrying the transcriptional fusion tssB::lucFF after incubation with K.
pneumoniae ATCC43816 (A) and A. baumannii ATCC17978 (B). Luminescence is expressed as relative light units (RLU) pero CFU (x109).
#, results are significantly different (P< 0.0001) for the indictaed comparisons; n.s., not significant (P> 0.05) from the results for mock-
treated Kp52145 (mock); one-way ANOVA Bonferroni correction for multiple comparisons. (C, D) T6SS-dependent anti-bacterial activity
as determined by recovery of target organisms K. pneumoniae ATCC43816 (Kp43816) (C), A. baumannii ATCC17978 (17978) (D)
following incubation with Kp52145, 52145-ΔphoPQGB (ΔphoPQ), 52145-ΔphoQGBComFLAG (ΔphoPQ::phoPQFLAG), 52145-
ΔphoQGBComPhoQ45-190 (ΔphoPQ::phoPQ45-190), and 52145-ΔphoQGBComPhoQGNNNNAQ (ΔphoPQ::phoPQGNNNNAQ). In all panels, #,
P< 0.0001, n.s. (P> 0.05), not significant differences from the results for PBS-treated (mock) target cell; one-way ANOVA Bonferroni
correction for multiple comparisons. In all panels, the data are presented as means ± the standard deviations (n = 3).
https://doi.org/10.1371/journal.ppat.1007969.g008
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Fig 9. Role of K. pneumoniae T6SS VgrGs in bacterial competition. (A, B, C) T6SS-dependent anti-bacterial activity as determined by recovery of
target organism K. pneumoniae ATCC43816 (Kp43816), A. baumannii ATCC17978 (17978), and B. cenocepacia K56-2 (K56-2) following
incubation with Kp52145, 52145-ΔclpV (ΔclpV), 52145-ΔvgrG1 (ΔvgrG1), 52145-ΔvgrG1 harbouring pBADVgrG1 (ΔvgrG1/ pBADVgrG1), 52145-
ΔvgrG2 (ΔvgrG2), 52145-ΔvgrG4 (ΔvgrG4), 52145-ΔvgrG4 harbouring pBADVgrG4 (ΔvgrG4/ pBADVgrG4), 52145-ΔvgrG2-ΔvgrG1 (ΔvgrG2-
ΔvgrG1), 52145-ΔvgrG1-ΔvgrG4 (ΔvgrG1-ΔvgrG4), 52145-ΔvgrG2-ΔvgrG4 (ΔvgrG2-ΔvgrG4), 52145-ΔvgrG2- ΔvgrG1-ΔvgrG4 (ΔvgrG2- ΔvgrG1-
ΔvgrG4). In all panels, #, P< 0.0001, n.s. (P> 0.05), not significant differences from the results for PBS-treated (mock) target cell; one-way ANOVA
Bonferroni correction for multiple comparisons. The data are presented as means ± the standard deviations (n = 3).
https://doi.org/10.1371/journal.ppat.1007969.g009
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NTUH-K2044 tssB mutants also resulted in decrease mortality as compared to the wild-type
strains (S12 Fig), demonstrating that the contribution of the T6SS to virulence in G. mellonella
is not dependent on the K. pneumoniae strain background.
We next sought to determine the relative contribution of Kp52145 VgrGs to virulence. 80%
of the larvae infected with 106 CFUs of the vgrG1 and vgr2 mutants survived whereas there was
no difference in survival between larvae challenged with the vgr4 mutant and the wild type
(Fig 11B). There were no differences in the mortality triggered by any of the double vgrG
mutants, and all of them killed only 25% of the challenged larvae after 120 h (Fig 11C). Infec-
tion with the triple mutant resulted in 100% survival of the infected larvae (Fig 11C). Control
experiments confirmed no differences in the growth of any of these strains in LB and minimal
medium (S13 Fig).
Altogether, these data provide evidence demonstrating that K. pneumoniae T6SS is essential
for virulence in the G. mellonella infection model. Our results also revealed that Klebsiella
pathogenicity in Galleria is combinatorial with all three vgrGs required to result in the overall
virulence phenotype.
VgrG4 is a toxin inhibited by the antitoxin Sel1E
Bioinformatics analysis of VgrG4 revealed that it encodes a C-terminus containing a DUF2345
domain of unknown function (Fig 12A). The presence of C-terminal extensions in VgrGs is
considered an indication of an effector function. Therefore, we sought to determine whether
VgrG4 is an antibacterial toxin. VgrG4 was cloned into pBAD30 to control the expression of
vgrG4 by arabinose. We also cloned vgrG1 and vgr2 into pBAD30 to assess whether expression
of any of the other vgrGs may have any deleterious effect in E. coli. The plasmids were intro-
duced into E. coli, and the toxicity of the proteins upon induction assessed by plating. Fig 12B
shows that expression of VgrG1 and VgrG2 in E. coli had no impact on E. coli recovery. In
stark contrast, induction of VgrG4 resulted in an 80% decrease in E. coli recovery (Fig 12A).
To assess the relative importance of VgrG4 domains for the antibacterial effect, we constructed
truncated variants of VgrG4 and investigated whether they retain the antibacterial effect.
Whereas the VgrG41-517 derivative did not affect E. coli recovery, VgrG4570-899, containing the
DUF2345 domain, exerted an antibacterial effect (Fig 12B), indicating that residues 570–899
are sufficient for the antibacterial effect. Moreover, VgrG4612-759 was enough to decrease E.
coli recovery (Fig 12B), indicating that VgrG4 DUF2345 domain is sufficient to trigger a toxic
effect. VgrG1 and VgrG2 also contain a DUF2345 domain. However, and in good agreement
with the fact that VgrG1 did not exert a toxic effect, VgrG1603-750, containing DUF2345
domain, had no impact on E. coli recovery (Fig 12B). Control experiments confirmed the
expression of the tagged versions of these proteins (S14 Fig).
We sought to determine whether VgrG4 will also exert a toxic effect when expressed in
eukaryotic cells. VgrG4, VgrG1 and VgrG2 were expressed as a GST-fusion under the control
of the inducible Gal1 promoter. We first evaluated their toxicity for the yeast cell upon induc-
tion in galactose-based medium, when the promoter is released from glucose-induced
Fig 10. K. pneumoniae T6SS-dependent antifungal competition. (A, B) T6SS-dependent anti-bacterial activity as
determined by recovery of target organism C. albicans, and S. cerevisiae following incubation with Kp52145, 52145-
ΔclpV (ΔclpV), 52145-ΔclpV complemented with pBADClpV (ΔclpV/pBADClpV), 52145-ΔvgrG1 (ΔvgrG1), 52145-
ΔvgrG1 harbouring pBADVgrG1 (ΔvgrG1/ pBADVgrG1), 52145-ΔvgrG2 (ΔvgrG2), 52145-ΔvgrG2 harbouring
pBADVgrG2 (ΔvgrG2/ pBADVgrG2), 52145-ΔvgrG4 (ΔvgrG4), 52145-ΔvgrG4 harbouring pBADVgrG4 (ΔvgrG4/
pBADVgrG4). After 6 h incubation in LB, target cells were recovered, diluted in PBS 0 to 10−6 and spotted in YNB agar
plate. Mock, PBS-treated C. albicans and S. cerevisiae. In all panels, #, P< 0.0001, n.s. (P> 0.05), not significant
differences from the results for PBS-treated (mock) target cell; one-way ANOVA Bonferroni correction for multiple
comparisons. The data are presented as means ± the standard deviations (n = 3).
https://doi.org/10.1371/journal.ppat.1007969.g010
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catabolic repression (S13 Fig). GST-VgrG4 caused a strong inhibition of yeast growth, whereas
GST-VgrG2 from the same strain was only toxic at high incubation temperatures (37 ºC) (S15
Fig). In contrast, GST-VgrG1 showed no effect on yeast growth (S15 Fig). These results
revealed the broad toxin function of VgrG4. By assessing truncated variants of VgrG4, we
showed that the variant containing the DUF2345 domain was sufficient to kill S. cerevisiae (Fig
12C). Control experiments confirmed the expression of the truncated VgrG4 variants in S. cer-
evisiae (S15B Fig). Collectively, these results demonstrate that VgrG4 is a bona fide T6SS toxin
and that the C-terminal extension containing the DUF2345 domain is sufficient for the anti-
bacterial and anti-eukaryotic effect.
In T6SS, protection against kin cells is conferred by the production of immunity proteins
that inhibit their cognate toxins. Immunity proteins are normally adjacent to the cognate
toxin. Downstream of vgr4 there are five genes of unknown function encoding sel-1 repeats
(Fig 1). To determine whether any of these genes assures protection against VgrG4, the genes
were expressed from the pMMB207 plasmid in E. coli harbouring pBADVgrG4. Induction of
Sel1D by IPTG did not alleviate VgrG4-triggered toxicity (Fig 12D). In contrast, induction of
Sel1E abrogated VgrG4-dependent killing (Fig 12D). Furthermore, Sel1E also conferred pro-
tection against the toxicity triggered by VgrG4570-899 and VgrG4612-759 containing the
DUF2345 domain (Fig 12D). Altogether, these results indicate that Sel1E is the immunity pro-
tein that protects against the toxic activity of VgrG4.
Sequence analysis and modelling of VgrG4
Since VgrG4 DUF2345 domain was shown to be responsible for the toxic effect of VgrG4, we
wanted to further explore its structure by homology modelling, which is a common method
for predicting the 3D structures of proteins based on the known structure of a related protein
[41]. To date, the P. aeruginosa VgrG1 (hereafter PaVgrG1) is the only structurally known full-
length VgrG protein. VgrG4 is however about 250 amino acids longer than PaVgrG1.
Sequence analyses show that the K. pneumoniae VgrG proteins belong to the T6SS, RhsGE-
associated Vgr protein (IPR006533) protein superfamily. PaVgrG1 belongs to the same super-
family, however, VgrG4 contains two domains that are not predicted to be found in PaVgrG1;
the Putative type VI secretion system, Rhs element associated Vgr domain (residues 490–592;
IPR028244) and the Domain of unknown function DUF2345, VgrG C-terminal (residues
612–759; IPR018769) (Fig 13A).
The 3D model for VgrG4 was created using the PaVgrG1 structure (PDB IDs 4uhv [42]) as
template for modelling. The trimeric VgrG4 forms a hollow tube with a larger head part (N-
terminus) and a narrow spike (C-terminus), connected by a neck region (Fig 13B). The head,
neck and N-terminal part of the spike (1–563) of VgrG4 was confidently modelled based on
the PaVgrG1 crystal structure. The 3D fold of this part is almost identical to PaVgrG1 and the
additional domains found in VgrG4 are located in the C-terminal part. Like PaVgrG1, the N-
terminal head of VgrG4 contains 24 beta-strands and 4 alpha helices from each monomer as
well as the irregular neck region connecting the head to the spike. The spike of the PaVgrG1
Fig 11. K. pneumoniae T6SS mutants displayed reduced virulence in the G. mellonella infection model. (A, B, C) Kaplan–Meier
plots showing the per cent survival of G. mellonella over 120 h post-infection with 105 organisms of the following strains: Kp52145,
52145-ΔclpV (ΔclpV), 52145-ΔtssB (ΔtssB), 52145-ΔvgrG1 (ΔvgrG1), 52145-ΔvgrG2 (ΔvgrG2), 52145-ΔvgrG4 (ΔvgrG4), 52145-ΔvgrG2-
ΔvgrG1 (ΔvgrG2-ΔvgrG1), 52145-ΔvgrG1-ΔvgrG4 (ΔvgrG1-ΔvgrG4), 52145-ΔvgrG2-ΔvgrG4 (ΔvgrG2-ΔvgrG4), 52145-ΔvgrG2- ΔvgrG1-
ΔvgrG4 (ΔvgrG2- ΔvgrG1-ΔvgrG4). Thirty larvae were infected in each group. Level of significance was determined using the log-rank
(Mantel–Cox) test with Bonferroni correction for multiple comparisons where applicable [a = (A) 0.0008; (B) 0.05]. P-values presented
correspond to the difference between (A) Kp52145 and the other strains, (B) Kp52145 and 52145-ΔvgrG1 (ΔvgrG1), 52145-ΔvgrG2
(ΔvgrG2), (C) Kp52145 and the other strains.
https://doi.org/10.1371/journal.ppat.1007969.g011
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Fig 12. VgrG4 is a trans-kingdom effector of K. pneumoniae T6SS. (A) Model of VgrG4 domains. (B) Recovery of E. coli cells following
induction of the ara promoter of the pBAD plasmid with arabinose (0.1%) for 60 min. #, P< 0.0001, n.s. (P>0.05), not significant
differences from the results for bacteria harbouring pBAD30 without arabinose induction, one-way ANOVA Bonferroni correction for
multiple comparisons.The data are presented as means ± the standard deviations (n = 3). (C) Growth on SD (glucose) and SG (galactose)
plates of serial dilutions of wild-type YPH499 yeast cells harbouring the indicated plasmids, and therefore expressing under the control of
the GAL1 promoter the corresponding proteins on galactose-based medium. Image is representative of three independent experiments.
(D) Recovery of E. coli cells following induction of the Ara promoter of the pBAD plasmid with arabinose (0.1%), and the tac promoter of
the pMMB207 plasmid with IPTG (1 mM) for 60 min. #, P< 0.0001, n.s. (P> 0.05), not significant differences from the results for bacteria
harbouring pBAD30 and pMMB207 without induction, one-way ANOVA Bonferroni correction for multiple comparisons.The data are
presented as means ± the standard deviations (n = 3).
https://doi.org/10.1371/journal.ppat.1007969.g012
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Fig 13. 3D model for K. pneumoniae VgrG4. (A) The bar represents the VgrG4 sequence and depicts the different parts that
were modelled (N-term: residues 1–563, Helix: residues 564–636, Repeat: residues 637–677, C-term: residues 678–739).
VgrG4570-899 (teal) containing the DUF2345 domain (612–759) intoxicates bacteria and yeast whereas VgrG4838-899 does not.
Monomeric 3D model of VgrG4 with the two regions of antiparallel beta strands (beta meander motif) encircled. (B) Trimeric
homology model of VgrG4. The functional part of VgrG4570-899 (teal) starts with the unique helical domains and continues with
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trimer is made up of 16 beta strands from each monomer, which forms a triangular-shaped
beta helix. The spike fold of VgrG4, however, is disrupted after the ninth confidently modelled
beta strand by a unique part lacking from PaVgrG1, which was separately modelled by I-TAS-
SER [43]. This part (Helix, residues 564–636, Fig 13A) has two long, almost parallel, alpha heli-
ces protruding from the spike fold (Fig 13B). After the helical domain, the spike fold continues
with 12 beta strands per monomer, since VgrG4 has 5 beta strands more than PaVgrG1. Simi-
lar to PaVgrG1, the VgrG4 spike has two regions of antiparallel strands (beta-meanders)
located in opposite ends of the spike (Fig 13C). Beta helical structures, like the VgrG spike, are
built upon a regular repeat pattern, which is formed by a repeat of eight residues, where 5–6
residues make up the beta strand and 2–3 residues form a loop between two beta strands [42].
Two hydrophobic residues of each beta strand are facing the interior of the spike in the beta-
meander regions, whereas they are mainly polar in the region with parallel beta strands. Simi-
lar conserved patterns that stabilize the fold were detected in VgrG4 and assisted in identifying
its second beta-meander region.
The modelled part (residues 1–739) ends with the putative PAAR interactions site (Fig
13B), which is followed by a proline-rich region that is unfavoured in beta strands and likely
disrupts the beta helical spike. We could not model the remaining C-terminal part (residues
740–899) containing the non-functional VgrG4838-899 construct (Fig 13A). Thus, the
DUF2345 domain containing part in the VgrG4 (Fig 13) that exerts antibacterial and antifun-
gal effects is predicted to be formed by the unique alpha helical domain and the C-terminal
part of the spike domain.
Sequence analysis and modelling of Sel1E
Our experiments show that Sel1E is the immunity protein for VgrG4 but that Sel1D is not able
to protect against VgrG4 toxicity. To analyse the structural basis for this functional difference
we compared the structures of Sel1E and Sel1D and analysed the evolutionary conservation of
the sequences. According to the InterPro [44] sequence analysis tool, the Sel1 proteins belong
to the Tetratricopeptide-like helical domain superfamily (IPR011990) and contains Sel1-like
repeats (IPR006597). The Tetratricopeptide repeat (TPR) motif consists of a 34 amino acid
consensus sequence that forms two antiparallel alpha helices connected by a turn. TPR motifs
are found in functionally very different proteins, however, most are involved in protein-pro-
tein interactions [45]. The Sel1 repeat (SLR) sequence is very similar to the TPR motif but is
usually 36–38 amino acids in length [46]. SignalP [47] and ScanProsite [48] predict that Sel1E
does not contain a lipoprotein signal sequence. Localization predictions made with web servers
Psortdb [49], CELLO [50] and Phobius [51] gave inconclusive results. Sel1E is about 70 resi-
dues longer than Sel1D (Fig 14A) and based on secondary structure predictions contains a
long loop region at the C-terminal end with only a few predicted secondary structure elements.
No information about potential domains or functions for this C-terminal region could be
found through sequence analysis searches.
In order to model Sel1E we used the threading-based method I-TASSER where we specified
as a restraint that the P. aeruginosa Pa5087 (PDB ID: 5jkp) [52] should be used as the structural
template. The C-terminal part of the sequence not covered by the template was modelled inde-
pendently by I-TASSER. Residues 28–289 were modelled with high confidence based on P.
the beta helical spike formed by 12 strands in each monomer. The separately modelled Helix part is inserted in the estimated
location, however, the exact orientation in relation to the rest of the protein is unknown. A PAAR protein from Vibrio cholerae
(PDB ID: 4jiv (23) is also shown to indicate the likely interaction site with the PAAR protein found in the VgrG4 locus. (C)
Monomeric 3D model of VgrG4 with the two regions of antiparallel beta strands (beta meander motif) encircled.
https://doi.org/10.1371/journal.ppat.1007969.g013
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Fig 14. Modelling of K. pneumoniae Sel1E. (A) Sequence alignment between Sel1D and Sel1E showing the residues (green) that
are both variable and predicted to be exposed by ConSurf. (B) MODFOLD residue accuracy prediction for the Sel1E I-TASSER
model. The colour scheme for the accuracy (Å): blue (high accuracy) through green, yellow and orange to red (low accuracy). (C)
Electrostatic surface potentials for Sel1E. The close-ups show the variable residues (green; marked by an asterisk in (A), which
contribute to the unique electrostatic potential surface of Sel1E, see text for more details. Due to the low confidence of the C-
terminal part of the model, only the region of high confidence was used for the comparison. The electrostatic surfaces were
calculated with the APBS tool (Adaptive Poisson–Boltzmann Solver) in PyMOL and the colour ranges from -7 to 7.
https://doi.org/10.1371/journal.ppat.1007969.g014
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aeruginosa Pa5087 (5jkp). In the MODFOLD [53] residue accuracy prediction the region
between residues 28–289 shows a high accuracy, whereas the C-terminal part show lower accu-
racy (Fig 14A). Thus, the I-TASSER model suggests that the N-terminal end of Sel1E shares
the typical fold of SLR-proteins while the structure of the C-terminal region could not be accu-
rately determined due to a lack of homologous structures.
Next, we used the ConSurf server [54] to predict exposed residues with potential for protein-
protein interactions (Fig 14A) and calculated the electrostatic potential of the protein surface
for the high confident region of the Sel1E model (Fig 14C). As our experiments show that
SEl1D is not the immunity protein for VgrG4 (Fig 12D), we compared Sel1E and Sel1D and
identified two regions with significant differences in the SelE and Sel1D sequences (Fig 14A,
green asterisk). The first one is an acidic patch formed by Asp230 and Glu251 and several Ser
and Thr residues (Fig 14C, top), whereas the second one is more positively charged due to the
two Arg residues (Fig 14C, bottom). Taken together this indicates that these residues in the SLR
domain of Sel1E could be important for the function of Sel1E and the interaction with VgrG4.
VgrG4-mediated antibacterial toxicity is dependent on reactive oxygen
species
T6SS antibacterial effectors can attack a number of cellular targets, including the peptidogly-
can, membranes and nucleic acids. However, bioinformatics comparisons of VgrG4 with
other well-characterized effectors did not provide any useful information to predict the anti-
bacterial action/target of VgrG4. Recent evidence supports the notion that lethal insults, such
as antibiotics, antimicrobial peptides and phage challenges, trigger ROS which contributes to
cell killing [55–57]. We therefore speculated whether the toxic effect of VgrG4 could be medi-
ated by ROS induction. To test this hypothesis, we asked whether VgrG4 expression up regu-
lates the expression of E. coli genes that respond to ROS stress [58]. Quantitative real time PCR
(RT-qPCR) experiments revealed that expression of VgrG4 induced the expression of soxS,
oxyS, oxyR, and katG (Fig 15A). The gene showing the strongest up regulation (more than
150-fold) was soxS, the transcriptional activator controlling the ROS regulon [58]. Moreover,
VgrG4570-899 and VgrG4612-759 were sufficient to increase the expression of genes responding
to ROS (Fig 15A). Interestingly, neither VgrG1 nor VgrG2 induced the expression of any of
the VgrG4-upregulated genes (Fig 15A), indicating that VgrG4-induced transcriptional
changes are specific. To test whether VgrG4 expression results in increased ROS levels, we
used the general ROS fluorescence sensor CM-H2DCFDA [59]. We found that ROS levels
were nearly 10-fold higher in E. coli expressing VgrG4 than in cells non-induced (S16A Fig).
VgrG4570-899 and VgrG4612-759 were sufficient to increase ROS levels (S16A Fig). Single cell
analysis by immunofluorescence further confirmed that VgrG4, VgrG4570-899, and VgrG4612-
759 triggered ROS in E. coli (Fig 15B, S16B Fig and S16C Fig). Quantification of the microscopy
images showed that only 1% bacteria (18 of 1620) were ROS positive if VgrG4 was not
induced. In contrast, 99% bacteria (2370 of 2394) were ROS positive upon induction of
VgrG4. Likewise, 99% and 84% bacteria were also ROS positive when VgrG4570-899, and
VgrG4612-759 were induced (2202 of 2208 and 4828 of 5738, respectively). Moreover, Kp52145
induced ROS in E. coli cells in contact with Klebsiella in contrast to the vgrG4 and clpV
mutants (S16D Fig). Complementation of vgrG4 restored Kp52145-induction of ROS in E. coli
(S16D Fig). Quantitative analysis revealed that 10% of E. coli cells (291 of 2795) not in contact
with Kp52145 were ROS positive. In stark contrast, 83% (2207 of 2663) of cells in contact with
Kp52145 were ROS positive. Only 1% of E. coli cells in contact with the clpV and vgrG4
mutants were ROS positive (21 of 2191 and 15 of 2345, respectively). Complementation of
vgrG4 resulted in 97% of E coli cells (3127 of 3215) being ROS positive.
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To determine whether VgrG4-induced ROS mediates cell killing, we asked whether a ROS
scavenger, ascorbic acid [59], may rescue E. coli from VgrG4-mediated killing. We found that
ascorbate fully protected E. coli from VgrG4, VgrG4570-899 and VgrG4612-759 -induced killing
Fig 15. VgrG4 toxic effect is ROS-dependent. (A) soxS, oxyS, oxyR, and kat levels assessed by RT-qPCR in E. coli harbouring the indicated
plasmids following induction of the Ara promoter of the pBAD plasmid with arabinose (0.1%) for 60 min. When indicated, ascorbate (15 mM)
was added to supplement LB. #, results are significantly different (P< 0.0001 [one-way ANOVA following Bonferroni correction for multiple
comparions]) from the results for bacteria harbouring pBAD30. The data are presented as means ± the standard deviations (n = 3). (B) Single-
cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA in E. coli harbouring pBADVgrG4 pMMBSel1E following
induction with arabinose and IPTG for 60 min. Hoechst was used to stain bacterial DNA. Images are representative of three independent
experiments. When indicated, ascorbate (15 mM) was added to supplement the culture media. (C) Recovery of E. coli cells following induction
of the Ara promoter of the pBAD plasmid with arabinose (0.1%) for 60 min, and in the presence or absence of ascorbate in the growth medium.
#, results are significantly different (P< 0.0001 [one-way ANOVA following Bonferroni correction for multiple comparions]) for the indicated
comparisons. The data are presented as means ± the standard deviations (n = 3).
https://doi.org/10.1371/journal.ppat.1007969.g015
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(Fig 15C). Further demonstrating the relationship between VgrG4-triggered ROS, and bacte-
rial killing, ascorbate abolished VgrG4, VgrG4570-899 and VgrG4612-759-induced increased ROS
levels (S16A Fig), and VgrG4, VgrG4570-899, and VgrG4612-759 -induced ROS in E. coli cells
(Fig 15B, S16B Fig, and S16C Fig). Quantification of E. coli cells showed that no more than 2%
of cells in which VgrG4, VgrG4570-899, and VgrG4612-759 were induced remained ROS positive
when incubated with ascorbate (9 of 1740, 48 of 1860, and 10 of 4609, respectively). As
expected, VgrG4, VgrG4570-899 and VgrG4612-759 did not upregulate the expression of E. coli
genes that respond to ROS stress when bacteria were incubated with ascorbate (Fig 15A). Col-
lectively, these findings demonstrate that ROS generation mediates the antibacterial effects of
VgrG4.
Having previously established that Sel1E protects against VgrG4-mediated toxicity, we
investigated whether Sel1E prevents VgrG4 induction of ROS. Expression of Sel1E abolished
VgrG4, VgrG4570-899 and VgrG4612-759 -induced ROS in E. coli (Fig 15B, S16B Fig and S16C
Fig). Analysis of the microscopy images showed that no more than 4% E. coli cells expressing
Sel1E were ROS positive (15 of 1331, 18 of 1701 and 250 of 5796). Furthermore, Kp52145 did
not trigger ROS in E. coli cells expressing Sel1E (S16E Fig). Only 17% of cells (511 of 3015)
expressing Sel1E and in contact with Kp52145 were ROS positive. Control experiments
showed that Sel1E is not a ROS scavenger because expression of Sel1E in E. coli did not prevent
ethanol-dependent upregulation of ROS (S17A Fig). Analysis of the images revealed that etha-
nol induced ROS in 100% of E. coli cells (2659 of 2659) expressing Sel1E. As anticipated,
VgrG4, VgrG4570-899 and VgrG4612-758 did not upregulate the expression of genes responding
to ROS in E. coli expressing Sel1E (S17B Fig). Altogether, these results suggest that Sel1E inhi-
bition of VgrG4-induced ROS mediates the protective effect of Sel1E.
Discussion
T6SS systems were initially studied for their interactions with eukaryotic cells, however sub-
stantial experimental data also argue for their role in microbial competition. Seminal studies
probing P. aeruginosa, V. cholerae, A. baumannii, S. marcescens and E. coli have uncovered
shared principles in terms of the structure of the secretion apparatus, and how effectors are
secreted. However, these studies have also revealed significant differences between bacterial
species, making it necessary to investigate different bacterial models to obtain a better picture
of the intricacies of the system. In this study, we provide a comprehensive characterization of
K. pneumoniae T6SS, demonstrating its role in microbial competition and uncovering new
aspects on how bacteria regulate T6SS-mediated antagonism.
Our in silico analysis revealed a significant diversity in how the T6SS is organized in K.
pneumoniae. Although all the strains analysed encode a complete T6SS including vgrG1, there
is diversity in the effector(s) and accompanying immunity protein(s). Additionally, strains
may carry additional T6SS loci each of them characterized by one vgrG and a set of effectors
and immunity proteins. The diversity found in K. pneumoniae T6SS reflects the considerable
genomic plasticity that is contained within this species as it has been shown in population
studies of this pathogen [24]. Notably, the effectors found in the analysed genomes are not
similar to any other effector found in other bacteria, suggesting that investigation of these
effectors will lead to the identification of new capabilities of T6SS effectors. Future structure-
function studies are warranted to capture the diversity of effectors in K. pneumoniae
pangenome.
It was somewhat unexpected to find the lack of bactericidal activity of Kp52145 against E.
coli prey in LB. This is one of the standard assays to demonstrate the activity of any T6SS.
However, our result is not unprecedented. For example, the bactericidal activity of E. coli
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EHEC is not detected in vitro [60], and that of P. aeruginosa H1-T6SS is only observed in the
background of mutants of the negative transcriptional regulator retS or the Threonine Protein
Phosphorylation (TPP) pathway governing the posttranslational regulation of the T6SS
[30,61]. On the contrary, the T6SS of S. marcescens Db10 and V. cholerae are constitutively
active [18,62]. We can only speculate why these differences exist between species, but they may
reflect the adaptation to niches with different pressures in term of microbial competition.
Nonetheless, it is not unreasonable to control tightly the T6SS given the energy costs to assem-
ble such a complex structure.
Here we have shown that environmental signals such as pH, iron, oxygen tension and
osmolarity control the expression of K. pneumoniae T6SS. Interestingly, those conditions
upregulating the expression of the system, slightly acidic pH, low oxygen tension, iron restric-
tion, and low osmolarity, are known environmental cues which may be faced by Klebsiella
while infecting the mucosal surfaces. The relevance of these signals in other niches, particularly
the environment, is largely unknown. In fact, there is a gap in the knowledge of the environ-
ment niches which might be colonized by K. pneumoniae. To shed further light into the regula-
tion of K. pneumoniae T6SS, we screened a panel of regulators to identify those controlling the
expression of the T6SS. Our results demonstrate that H-NS is a negative regulator of K. pneu-
moniae T6SS. The fact that this is a shared feature with other bacteria supports the notion that
H-NS acts as a general silencer of the T6SS [60,63,64]. Our findings also reveal that RcsB and
MgrB are negative regulators of the T6SS. The latter is particularly relevant because the vast
majority of K. pneumoniae isolates resistant to the last line antibiotic colistin encode loss of
function mutations of mgrB [65,66]. It can be then postulated that the T6SS is upregulated in
these strains, resulting in increased microbial antagonism activity. Mechanistically, we have
established that the increase activity of the T6SS in the mgrB and rcsB mutant backgrounds is
dependent on the upregulation of the two-component system PhoPQ. In fact, our data indicate
that this system acts as a positive regulator of the T6SS. PhoPQ is widely recognized as one of
the master regulators governing the bacterial surface of Gram-negative bacteria, chiefly the
LPS. This is also true for K. pneumoniae, and, for example, the dramatic lipid A remodelling
observed in mgrB and rcsB mutants is PhoPQ-dependent [31,32]. This raises an interesting
question whether there is a linked between the T6SS and the lipid A structure. It may well be
that the assemble of the T6SS may require a certain lipid A structure, or perhaps that Klebsiella,
as a result of an adaptation to mucosal environment, coordinates the expression of the T6SS
and the LPS to interact with the immune system and competing microbes. We envision that
this scenario is relevant in the context of gut colonization. Future studies are warranted to
investigate these questions.
Further supporting a connection between the T6SS and the LPS, we have shown that the
LPS-interacting antimicrobial peptides, polymyxin B, colistin, and HBD3, upregulated the
expression of the T6SS with a concomitant increase in the bactericidal activity. The facts that
these agents trigger perturbations in the cell membrane, and that PhoPQ mediated this upre-
gulation strongly suggest that an alteration of the cell membrane is the signal sensed by Klebsi-
ella to control the expression of the T6SS. It is then not surprising that the PhoQ periplasmic
domain, and the acid patch within it, is essential for PhoQ-mediated regulation of the T6SS
because this same domain also senses cell surface perturbations caused by antimicrobial pep-
tides [67]. Collectively, these findings support a model in which cell surface instability is a
major signal controlling the T6SS. Interestingly, similar observations have been reported for P.
aeruginosa [68,69]. Membrane targeting agents such as cation chelators, and polymyxin B also
activate P. aeruginosa H1-T6SS [68,69]. However, it is important to mark that in Pseudomonas
this activation is through posttranslational control whereas in Klebsiella is via transcriptional
control.
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Our data revealed that K. pneumoniae also perceives T6SS attacks from bacterial competi-
tors, resulting in retaliation against the aggressive cell. The perception of the attack involves
the PhoPQ system via transcriptional regulation of the T6SS. The fact that the periplasmic
domain of PhoQ is required to sense the attack strongly argues that Klebsiella detects the enve-
lope perturbation after T6SS-mediated perforation. Supporting this notion, K. pneumoniae
does not antagonize attackers in which the T6SS was mutated. Nonetheless, we cannot rigor-
ously exclude that Klebsiella might detect a common structural feature of the proteins located
in the T6SS apparatus upon contact, or even the delivery of T6SS effectors.
In this study, we also show that K. pneumoniae T6SS mediates the intoxication of yeast spe-
cies C. albicans and S. cerevisiae. Our results follow the landmark study demonstrating that S.
marcescens displays antifungal activity [70]. This T6SS-dependent cross-kingdom antagonism
may be a widespread feature of the T6SS because it has been already found in P. syringae [71],
and the Serratia T6SS effector responsible for the fungi intoxication is also encoded by P. aeru-
ginosa and V. cholerae [70]. The antifungal activity may result beneficial for Klebsiella given
that fungi and Klebsiella colonize common sites such as the gut, and the respiratory system
although it is also possible that this fungicidal action may be also important in the
environment.
We have uncovered that K. pneumoniae has a preference for different VgrGs depending the
conditions. VgrG1 is essential in all conditions tested except antifungal competition, VgrG2 is
required for antibacterial competition in LBpH6, and antifungal competition, whereas VgrG4 is
needed for antibacterial competition in LBNaCl, and to intoxicate kin, non-kin and fungi.
Based on the in silico analysis shown in Fig 1, and the accepted notion that specific effectors
are absolutely dependent on particular VgrG for delivery, we can then assume that K. pneumo-
niae exploits a different repertoire of effectors depending on the condition. Taken together, it
can be postulated that K. pneumoniae T6SS forms at least three different assemblies, each of
them characterized, at least, by one VgrG protein. Future studies are warranted to characterize
structurally these putative different assemblies and to define the effector(s) delivered by each
of them.
Another novel finding of this work is the identification of VgrG4 as a K. pneumoniae T6SS
effector. To date, the only T6SS effectors characterized in K. pneumoniae are phospholipases
[22,23]. Structurally, the DUF2345 domain of VgrG4 was sufficient to intoxicate bacteria and
yeast. Based on the results presented in this work, we propose to name this domain as ROS
toxic domain (RTD). Our homology model shows that the DUF2345 domain consists of a
novel helical domain (Fig 13B) followed by the typical beta helical fold of the VgrG spike.
Notably, this domain is present in other VgrGs and, therefore, it can be predicted that the
effector function of this domain is widespread in different bacterial species. It is interesting to
note that Serratia effectors showing anti-fungal activity were not toxic for bacteria [70],
whereas we have shown that VgrG4 is toxic for both bacteria and fungi, uncovering the com-
plexity and diversity of T6SS effectorts.
Flaugnatti and colleagues [72], have shown that DUF2345 domain present in entero-aggre-
gative E. coli VgrG1 contributes to the delivery of the effector phospholipase Tle1. In fact,
VgrG1 and VgrG2 also contain this domain and they were not toxic for E. coli. Furthermore,
VgrG1 DUF2345 did not exert any toxic effect. Taken together the published evidence and the
data presented here, we postulate that RTD like domains mediate trans-kingdom intoxication
while most likely also deliver effectors. In the case of VgrG4 we postulate that the phospholi-
pase effector PlD1, encoded downstream of VgrG4, will be the effector delivered (Fig 1A). On
the other hand, VgrG1 and VgrG2 like DUF2345 domains will only deliver effectors. Future
studies are warranted to test this hypothesis probing different DUF2345 domains found in
VgrGs from different bacterial species.
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VgrG4-mediated toxic effect is dependent on the induction of ROS because a known ROS
scavenger rescued bacteria from VgrG4-induced lethality. Furthermore, VgrG4-induced ROS
is sensed by the prey resulting in upregulation of systems aiming to alleviate ROS-imposed
stress, chiefly those controlled by SoxS. Truncation experiments revealed that vgrG4 DUF2345
domain, now named as RTD, was sufficient to induce ROS, and the activation of soxS, further
connecting lethality and ROS induction. In this work, we have also identified Sel1E as the
VgrG4 antitoxin. Mechanistically, Sel1E inhibition of VgrG4-induced ROS mediates the pro-
tective effect of Sel1E. It is important to note that Sel1E is not a general ROS scavenger.
Instead, and similarly to other T6SS antitoxins, we predict Sel1E will interact with VgrG4 to
mitigate its toxic effect. The fact that Sel1E also blunts toxicity induced by the VgrG4 RTD
domain and ROS induced by this domain suggests that this domain is the region of VgrG4
interacting with Sel1E. Based on our results, the SLR domain of Sel1E might mediate these
interactions as the SLR repeat proteins are commonly involved in the protein-protein interac-
tions [73].
To our knowledge, VgrG4 is the first T6SS effector for which a ROS-dependent lethality has
been conclusively demonstrated. However, we believe that this can be a more widespread fea-
ture of T6SS effectors. Recently it has been shown that V. cholerae and A. baylyi T6SS attacks
trigger ROS induction in the E. coli prey [57]. Our results add further evidence to the notion
that ROS generation contributes to bacteria lethality. For example, and despite the initial con-
troversy, substantial data support that antibiotic-induced ROS contributes to their bactericidal
effect in addition to their primary lethal action [56,59]. Other lethal insults such as antimicro-
bial peptides, and phage attack also induce ROS and trigger the upregulation of soxS [57].
Taken together, these results indicate that ROS generation, and the concomitant effect of ROS
in gene regulation, could be considered an early event in bacterial antagonism.
Materials and methods
Bacteria and growth conditions
Bacterial strains and plasmids used in this study are shown in Table 1. Kp52145 is a clinical iso-
late, serotype O1:K2, belonging to the virulent CC65 clonal complex. B. cenocepacia and A.
baumannii strains have been described elsewhere and were kindly donated by Miguel Valvano,
Mario Feldman and Suzana Salcedo. Unless otherwise indicated, bacteria were grown in 5-ml
LB medium in a 15-ml plastic tube at 37ºC in a shaker (180 rpm). When appropriate media
were supplemented with antibiotics at the following concentrations: ampicillin (Amp) 100 μg/
ml, trimethoprim (Tmp) 100 μg/ml, tetracycline (Tet) 12.5 μg/ml, chloramphenicol (Cm)
25 μg/ml, kanamycin (Km) 50 μg/ml, carbenicillin (Cb) 50 μg/ml, apramycin (Apra) 50 μg/ml.
Growth curve analysis
For growth analyses, 5 μl of overnight cultures were diluted in 250 μl of LB, M9 minimal
medium (5× M9 minimal salts [Sigma-Aldrich] supplemented with 2% glucose, 3 mM thia-
mine, 2 mM MgSO4) or modified LB, and incubated at 37˚C with continuous, normal shaking
in a Bioscreen C Automated Microbial Growth Analyzer (MTX Lab Systems, Vienna, VA,
USA). Optical density (OD, 600 nm, [OD600]) was measured and recorded every 20 min.
Capsule polysaccharide purification and quantification
Bacteria were grown overnight in 3 ml of LB medium (37˚C, 180 rpm) with viable counts
determined by dilution plating. The cultures were then harvested by centrifugation, and the
cell pellet resuspended in 500 μl of sterile water. Each sample was then treated with 1% 3-(N,
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N-dimethyltetradecylammonio)propanesulphonate (Sigma-Aldrich; in 100 mM citric acid,
pH 2.0) at 50˚C for 20 min. Bacterial debris was pelleted (3,220 × g, 10 min), and 250 μl of the
supernatant were transferred to a clean 15-ml glass tube. The CPS was ethanol-precipitated at
−20˚C for 20 min and pelleted (9,447 × g, 10 min, 4˚C). After removal of the supernatant, the
pellet was then dried (5 min, 90˚C) and resuspended in 200 μl of sterile water. CPS quantifica-
tion was undertaken by determining the concentration of uronic acid in the samples, using a
modified carbazole assay as previously described [74]. All samples were tested in duplicate.
String test
A loop was used to lift a portion of a colony from a fresh LB agar plate of K. pneumoniae. The
formation of viscous strings of>5 mm in length indicates a positive string test [75]. The string
test was done on nine randomly chosen colonies from three independent plates.
Bioinformatics mapping of the T6SS clusters
The unidentified genes within the T6SS clusters underwent a manual annotation process
based on description of similarity. Pfam and COG database searches, as well as TMHMM and
predictions were performed to improve the degree of annotation confidence, if necessary.
Artemis, NCBI BLAST and SecRet6 database queries [76] were also used to statistically analyse
unidentified proteins within the genomes of K. pneumoniae strains. These programs identify
clusters of T6SS core components using HMMER, the amino acid sequence of the unknown
proteins within the cluster are then blasted (BLASTP with a cut off of 105) to putatively identify
genes.
To examine T6SS diversity across the wider K. pneumoniae population, we downloaded all
available K. pneumoniae genomes from the NCBI SRA (as of November 2018), and con-
structed a MASH distance phylogeny. From this we selected 700 genomes to represent the
phylogenetic diversity of the species. We performed de novo assembly using Spades v 3.12.0
[77] and annotation using Prokka v 2.9 [78]. The nucleotide sequence component and effector
databases of SecRet6 were downloaded and converted into a blastable database in Abricate
using the abricate–setupdb command on the downloaded sequence (https://github.com/
tseemann/abricate). Using Abricate all 700 genomes were blasted against the T6SS databases
individually, and the results combined into a single csv file using the abricate–summary com-
mand (S1 Data, S2 Data). A phylogenetic tree (S3 Data) of the 700 genomes was obtained
using Parsnp [79]. In Parsnp, all 700 assembled genomes are rapidly aligned using localised
colinear blocks of orthologous sequence, and the alignment used to create a rapid maximum
likelihood phylogenetic tree, with branch lengths indicative of nucleotide substitutions per
site. The gene presence-absence data from Abricate was visualised against the tree using Phan-
dango [80]. To investigate the number of orthologs of vgrG1 we used the gene sequence from
genome Kp52145 to blast against the 700 genomes using blastn. All genes returning an ortho-
logous Blast hit of over 350 consecutive nucleotides with an e-value at or close to zero were
selected and investigated by blastn against the non-redundant database to confirm their iden-
tity as likely vgrG1 orthologs.
Marker-less mutation in K. pneumoniae
PCR primers used to construct the mutants were designed using the whole genome sequence
of Kp52145 (GenBank Accession No. FO834906.1). The primer pairs (S1 Table) were used in
separate PCR reactions to amplify ~1000-bp fragments flanking the gene to be mutated.
BamHI restriction sites internal to these flanking regions were incorporated at the end of each
amplicon. Purified fragments were then polymerised and amplified as a single PCR amplicon
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using the primers gene_UPFWD and gene_DWNRVS. These amplicons were cloned into
pGEM-T Easy (Promega), and transformed into E. coli C600. After EcoRI digestion of the plas-
mids, the purified fragments were cloned into EcoRI-digested Antarctic Phosphatase (New
England Biolabs)-treated pGPI-SceI-2 suicide vector [81] to generate pGPI-SceI-2Δ_gene, and
transformed into E. coli GT115 or SY327. pGPI-SceI-2Δ_gene was thereafter transformed into
the diaminopimelate (DAP) auxotrophic E. coli donor strain β2163 [82], and mobilised into K.
pneumoniae by conjugation. Selection of co-integrant clones was undertaken using LB agar
supplemented with Tmp at 37˚C. A second crossover reaction was then performed by conju-
gating the pDAI-SceI-SacB plasmid [81] into a refreshed overnight culture containing three
Tmp-resistant co-integrant clones. Exconjugants were selected on LB agar supplemented with
Tet at 37˚C. Candidate clones were checked for susceptibility to Tmp and then confirmed by
PCR. Curing of the pDAI-SceI-SacB vector was performed by plating a refreshed overnight
culture of one K. pneumoniae mutant colony onto 6% sucrose LB agar without NaCl at 30˚C
for 24 h. A single clone surviving the sucrose treatment was checked for susceptibility to Tet,
confirmed by PCR and named 52145-Δ_gene (Table 1). The CPS levels, the mucoviscosity,
and the growth of the mutant strains were assessed as previously described. No differences
were found between any of the mutants constructed and the corresponding isogenic wild-type
strain.
Complementation of vgrG and clpV mutants
To complement the single vgrG and clpV mutants, a PCR fragment comprising the coding
region of each vgrG was amplified using primers indicated in S1 Table. The amplicon was
digested with EcoRI and HindII in the case of vgrG1 and vgrG4 and clpV, and ScaI and XbaI in
the case of vgrG2. The fragments were gel-purified and cloned EcoRI-HindIII and ScaI-XbaI-
digested pBAD30, respectively, to obtain pBADVgrG1, pBADVgrG2, pBADVgrG4 and
pBADClpV (Table 1). These plasmid were transformed into E.coli β2163, and then mobilized
into each of the Klebsiella vgrG and clpV mutants by conjugation.
Generation of the lucFF reporter fusion K. pneumoniae strains
A 1 kpb amplicon comprising the tssB, tssK2 and sciZ3 gene promoter regions were amplified
using Phusion High-Fidelity DNA Polymerase and the primers protssB / protssK /
proomp_FWD and protssB / protssK / proomp_RVS (S1 Table). The amplicons were digested
with EcoRI, gel-purified, cloned into an EcoRI-SmaI-digested, Antarctic Phosphatase (New
England Biolabs) pGPL01 suicide vector and then transformed into E. coli GT115 cells to
obtain pGPLKpnProtssB, pGPLKpnProtssK2, and pGPLKpnPrsciZ3. Correct insertion of the
amplicons were verified by restriction digestions with EcoRI and SmaI. Vectors were intro-
duced into E. coli β2163, and then mobilised into K. pneumoniae strains by conjugation. Cul-
tures were then serially diluted and checked for Amp resistance by plating on LB Cb agar at
37˚C. Correct insertion of the vectors into the chromosome was confirmed by PCR using the
relevant lucFF_check and promoter sequence primers (S1 Table).
Antibacterial competition assay
Attacker K. pneumoniae strains and preys were grown until mid-exponential phase, collected
by centrifugation, washed three times with PBS, and resuspended in PBS to an OD600 of 1.
Attacker and preys were mixed at 10:1 ratio, and the mixture spot it in a pre-warmed agar
plate at 37˚C. The mixture was incubated for 6 hours. Recovered cells were plated out on anti-
biotic selective media and viable cells were reported as recovery target cell representing the
CFU per ml of the recovered prey after co-culture. Burkholderia strains were selected by
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plating on Tmp (50 μg/ml), Acinetobacter strains by plating on Cm (10 μg/ml), and Klebsiella
strains by plating on Cb (50 μg/ml), All experiments were carried out with triplicate samples
on at least three independent occasions.
Antifungal competition assay
S. cerevisiae and C. albicans were grown in YPD (Peptone (20% w/v), Yeast Extract (10% w/v),
Dextrose (20% w/v)) overnight at 30 ºC with agitation (180 r.p.m.). Cells were then adjusted in
PBS to yield 5x107 cells/ml. K. pneumoniae strains were grown to mid exponential phase,
washed three times in PBS, and the suspension adjusted to an OD600 of 1 in PBS. Klebsiella
and eukaryotic cells were mixed at a 10:1 ration (predator:prey), and 50 μl of the mixture were
spotted in pre-warm LB plate and incubated for 6 h at 37˚C. Cells were recovered, serially
diluted in PBS and plated on YNB (YNB 0.67% w/v, Dextrose 20% w/v) medium containing
Km. All experiments were carried out with duplicate samples on at least three independent
occasions.
Luciferase activity
Overnight cultures of the K. pneumoniae reporter strains were refreshed until mid-exponential
phase in the appropriated media. The cells were then pelleted, washed once in sterile PB buffer
(1M disodium hydrogen orthophosphate, 1.5 mM potassium dihydrogen orthophosphate, pH
7.0) and adjusted to an OD600 of 1.0. One hundred microlitres of each suspension were added
to an equal volume of luciferase assay reagent (1 mM d-luciferin [Synchem] in 100 mM
sodium citrate buffer pH 5.0), vortexed for 5 s and then immediately measured for lumines-
cence (expressed as relative light units [RLU]) using a GloMax 20/20 Luminometer (Promega).
All strains were tested in quadruplicate from three independent cultures.
To determine luciferase activity of bacteria grown in solid media, reporter strains were
incubated with preys as described in the antibacterial competition assay for 6 hours. The mix-
ture was then recovered with 1 ml of PB buffer in a microcentrifuge tube. Bacteria were col-
lected by centrifugation (13,300 rpm, 2 mins), washed with 1 ml of PB buffer, and adjusted to
an OD600 of 1.0. One hundred microlitres were used to assess luminescence. All strains were
tested in quadruplicate from three independent cultures.
For those experiments in which reporter strains were incubated with Klebsiella, Acinetobac-
ter and Burkholderia strains, pGEMTApra was introduced into the reporter strains by electro-
poration. Bacteria were incubated as indicated in the antibacterial competition assay.
Luminescence was determined as previously described. The number of reporter bacteria in the
sample was determined by plating on apramycin (50μg/ml). Results are expressed as RLU per
CFU (x109). All strains were tested in triplicate from three independent cultures.
Site-directed mutagenesis of phoQ
The phoPQ promoter and coding region including a FLAG-tag was amplified by PCR using
primers Kp52_PhoPQ_compF1 and Prom_PhoPQ_FLAG_R1, gel-purified and cloned in to
pGEM-T Easy to give pGEMTPhoQPFLAG. To delete the periplasmic region of PhoQ, 45–
190 aminoacids [39], we followed the protocol described by Byrappa and co-workers [83]
using primers Kp52_PhoPQ_SDM_F2 and Kp52_PhoPQ_SDM_R2 (S1 Table), and Vent
polymerase to obtain pGEMTPhoQ45-190. To mutate the acidic patch, aminoacids 148 to 154,
within the periplasmic region of phoQ from EQGDDSE to GNNNNAQ, we used primers
Kp52_PhoQ_Acidic_F2 and Kp52_PhoQ_Acidic_R2 to obtain pGEMTphoQGNNNNAQ. The
region corresponding to phoQ in pGEMTPhoQ45-190 and pGEMTphoQGNNNNAQ were
sequenced to ensure that no additional changes were introduced in the coding region. The
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wild-type and mutated alleles were obtained by EcoRI digestion, gel-purified and cloned
into pUC18R6KT7mini-Cm vector to obtain pUC18r6KT7mini-Cm PhoQ45-190 and
pUC18r6KT7mini-Cm phoQGNNNNAQ which were then transformed into E. coli C600 and
thereafter into E. coli β2163. In addition, the transposase-containing pSTNSK-Tmp plasmid
[84] was introduced to the 52145-ΔphoQ strain by electroporation to give 52145-ΔphoQ /
pSTNSK-Tmp. This strain was then conjugated overnight with E. coli β2163 containing the
phoQ alleles on LB agar supplemented with DAP at 30ºC. The retrieved mixture was then seri-
ally diluted in sterile PBS, plated onto LB Cm agar and incubated at 42ºC for 6.5 hours fol-
lowed by overnight incubation at 37˚C. The colonies grown were thereafter screened for
resistance to Amp and susceptibility to Cm. Correct integration of the Tn7 transposon was
confirmed by PCR using the primers KpnglmSup/Ptn7L and KpnglmSdown/Ptn7R as previ-
ously described [31,85]. Additionally, presence of the phoQ gene was PCR confirmed using
Kp52_PhoPQ_compF1 and Prom_PhoPQ_FLAG_R1 primers (S1 Table).
Sequence analysis and modelling
VgrG4 sequence (W9BAA4) was obtained from the UniProt Knowledgebase. A search for
homologous crystal structures, which could be used as template structures, was performed
with the Basic Local Alignment Search Tool (BLAST) against the Protein Data Bank using the
VgrG4 sequence as query. Three structures were found: P. aeruginosa VgrG1 (PDB ID: 4uhv
[42], 4mtk (Sycheva et al. to be published) and E. coli v3393 protein (PDB ID: 2p5z [86]).
BLAST searches were also made in order to find sequences similar to both VgrG4 and
PaVgrG1. Symmetry mates for PaVgrG1 (PDB ID: 4uhv [42]) were created in PyMOL in
order to obtain the VgrG4 trimer.
BLAST searches against the pdb database were likewise made using the Sel1E (W9BPL7)
sequence as queries. Only two structures (P. aeruginosa Pa5087 PDB ID: 5jkp and P. aerugi-
nosa PA5087 PDB ID: 5jjo [52]) had an e-value< 0.001.
To determine the different domains of the protein, the sequences were analyzed with Inter-
Pro [44] and Prosite [48] and the secondary structures were predicted with PSIPred [87]. Sig-
nalP [47] was used to determine if the proteins contain any signal sequences and localization
predictions were made with Psortdb [49], CELLO [50] and Phobius [51]. ConSurf [54] was
used to analyze the evolutionary conservation. Pymol (The PyMOL Molecular Graphics Sys-
tem, Version 2.0 Schro¨dinger, LLC.) was used for visual inspection of the models and for creat-
ing pictures and the ABPS plugin was used to calculate the electrostatic potential of the protein
surfaces.
The modelling of VgrG4 was performed in four separate parts. First, a structure-based
sequence alignment was made for the N-terminal part (residues 1–563) using the crystal struc-
tures of PaVgrG1 (PDB ID: 4uhv [42], 4mtk (Sycheva et al. to be published)) and the E. coli
v3393 protein (PDB ID:2p5z [86]). A few sequences similar in length to PaVgrG1 and to
VgrG4, respectively, were aligned to the prealigned structural alignment to create the multiple
sequence alignment for residues 1–563 (N-term), which were modelled using PaVgrG1 resi-
dues 1–549 as the structural template. Secondly, a region of the spike part (residues 564–636)
in VgrG4 is predicted by PSIPred to contain two long alpha helices, which have no corre-
sponding part in the PaVgrG1 protein. This part (Helix) was therefore modelled separately by
the I-TASSER threading-method server [43], which uses multiple structural templates and
builds a model by assembling fragments from the different templates. Thirdly, we made use of
the repetitive pattern found in PaVgrG1 to model residues 637–677 (Repeat) by using a
repeated part of the PaVgrG1 protein (residues 551–589) as structural template. Finally, resi-
dues 678–739 (C-term) were modelled based on the C-terminal part of PaVgrG1 (residues
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550–611). 3D models for the N-terminal, Repeat and C-terminal parts were made with the
homology modelling program Modeller [88], which created ten models, and the one with the
lowest energy according to the Modeller objective function was then used for further analyses.
Of the two homologous PaVgrG1 structures (PDB IDs 4uhv [42], 4mtk (Sycheva et al. to be
published), 4uhv was chosen as template for modelling VgrG4 since a few amino acids were
missing (amino acids 1–4 and 641–643) from the 4mtk structure.
Sel1E was modelled with the threading server I-TASSER [43] and based on the homologs
found in the BLAST search we added a restraint, which specified that I-TASSER would use the
P. aeruginosa Pa5087 protein (PDB ID: 5jkp) as the template. The remaining part of the Sel1E
protein, with no corresponding part in the template, were modelled independently by
I-TASSER.
The models were visually inspected and evaluated by superimposition with the template
structures using the program VERTAA in the Bodil modeling environment [89]. All models
were also evaluated by the online model quality evaluation servers Qmean [90], PROSAweb
[91], ProQ [92] and MODFOLD [53].
Real time quantitative PCR to assess the expression of genes induced by
ROS
Bacteria were collected in the exponential phase of growth, washed with PBS, and adjusted to
an OD600 of 1 in PBS. 1 ml of this suspension was pelleted and resuspended in 1 ml of TrIzol
(Invitrogen). RNA was purified following the indications of the manufacturer. The quality of
the purified RNA was assessed using a nanodrop (NanoVue Plus). cDNA was generated from
1 μg of RNA using Moloney murine leukaemia virus (M-MLV) reverse transcriptase (Sigma-
Aldrich) according to the manufacturer’s instructions. Quantitative real-time PCR analysis of
gene expression was undertaken using the KAPA SYBR FAST qPCR Kit and Rotor-Gene Q
instrument system (Qiagen). Thermal cycling conditions were as follows: 95˚C for 3 min for
enzyme activation, 40 cycles of denaturation at 95˚C for 10 s and annealing at 60˚C for 20 s.
Primers used in qPCR reactions are listed in S1 Table. cDNA samples were tested in duplicate
and relative mRNA quantity was determined by the comparative threshold cycle (ΔΔCT)
method, using rrsA gene for normalisation.
Fluorescence dye-based detection of ROS
E. coli MG1655 was grown until mid-exponential phase, bacteria were pelleted from 1-ml of
the culture, washed once with PBS, and resuspended in 1-ml PBS. CM-H2DCFDA (Life Tech-
nologies, from 1 mM strock solution in 100% DMSO (vol/vol)) was added to bacteria to a final
concentration of 10 μM. The mixture was incubated from 30 min at room temperature (20–
22˚C). One hundred microliters of the resultant cell suspension samples were transferred to a
96-well black plate, and fluorescence measured using a SpectraMax M2 Plate Reader (Molecu-
lar Devices) with excitation/emission wavelengths of 495/520 nm, and a slit width 1cm. Results
are expressed as relative fluorescence units (RFU). All experiments were carried out with quin-
tuple samples on at least three independent occasions.
Single cell assessment of ROS by microscopy
E. coli MG1655 was grown until mid-exponential phase, and CM-H2DCFDA was added to the
culture to a final concentration of 10 μM. One millilitre of the culture was spun down, washed
twice with PBS and incubated in a 37˚C water bath for 30 min. 1 ml bacterial culture was then
concentrated 10-fold by centrifugation, and 5 μl were spotted on a 1% agarose (w/v) pad con-
taining 10 μM CM-H2DCFDA. After 30 min incubation at room temperature, fluorescence
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images were captured using the ×100 objective lens on a DM5500 microscope (Leica)
equipped with the appropriate filter sets. Acquired images were analysed using the LAS imag-
ing software (Leica).
For imaging of ROS in E.coli in contact with K. pneumoniae, Kp52145 and E. coli MG1655
harbouring pJT04-mCherry were grown until mid-exponential phase, and CM-H2DCFDA
was added to the E. coli culture to a final concentration of 10 μM. Bacteria were collected by
centrifugation, washed with PBS, and mixed at 10:1 ratio (Klebsiella:E. coli). 1 ml of the sample
were concentrated 10-fold by centrifugation, and 5 μl were spotted on a 1% agarose pad con-
taining 10 μM CM-H2DCFDA. After 6 h incubation at 37˚C, Klebsiella was labelled with rab-
bit anti-Klebsiella serum (1:1000) and visualised with goat anti rabbit Alexa Fluor 350 life-tech
(1:1000) (Molecular Probes, A11046). Fluorescence images were captured using the ×100
objective lens on a Leica DM5500 microscope equipped with the appropriate filter sets.
Acquired images were analysed using the LAS imaging software (Leica).
Infection of Galleria mellonella larvae
G. mellonella larvae were obtained from UK Waxworms Limited. Upon receipt, larvae were
stored in reduced light at 13˚C with nil dietary supplementation. All experiments were per-
formed within 7 days of receipt comprising larvae of 250–350 mg weight showing a healthy
external appearance as previously described [40]. K. pneumoniae strains were prepared by har-
vesting refreshed 5 ml of exponential phase LB cultures (37˚C, 180 rpm, 2.5 h), washing once
in sterile PBS and then adjusting to an OD600 of 1.0 (i.e. ~5 × 108 CFUs/ml). Each suspension
was thereafter diluted to the desired working concentration. Larvae were surface-disinfected
with 70% (v/v) ethanol and then injected with 10 μl of working bacterial suspension at the
right last proleg using a Hamilton syringe equipped with a 27-gauge needle. For each experi-
ment, 10 larvae injected with sterile PBS were included as combined trauma and vehicle con-
trols. Injected larvae were placed inside Petri dishes at 37˚C in the dark. Larvae were
considered dead when unresponsive to physical stimuli. Larvae were examined for pigmenta-
tion and time of death was recorded. The virulence assay was performed in triplicate (30 larvae
total per strain).
Cloning of Hcp1
hcp1 was amplified by PCR using primers Hcp2467pBAD30_EcoRI_F1 and
Hcp2468pBAD30_HindIII_R1 (S1 Table), primer Hcp2468pBAD30_HindIII_R1 contains a
VSV-G tag. The amplicon was gel-purified, digested with EcoRI and HinIII, gel-purified, and
cloned into an EcoRI-HindIII-digested, Antarctic Phosphatase (New England Biolabs) treated
pBAD30 expression vector to give pBADHcp1VSV. This plasmid was then transformed into
E. coli β2163, and mobilized into K. pneumoniae strains by conjugation.
Cloning of VgrG tagged proteins
vgrG1, vgrG2, and vgrG4 were amplified with primers indicated in S1 Table containing a
FLAG tag. vgrG41-517 and vgrG4570-899 were amplified with primers containing a VSV-G tag
(S1 Table), whereas vgrG1603-750 and vgrG4612-759 were amplified with primers containing a
FLAG tag (S1 Table). The amplicons were gel-purified, and digested with EcoRI in the case of
vgrG1, vgrG2, vgrG4, vgrG1603-750 and vgrG4612-759 and Xho1 in the case of vgrG41-517 and
vgrG4570-899.These digested fragments were then gel-purified, and cloned into EcoR1 or Xho1
digested, Antarctic Phosphatase (New England Biolabs) treated pBAD30 expression vectors to
give pBADVgrG1FLAG, pBADVgrG2FLAG, pBADVgrG4FLAG, pBADVgrG41-517VSV,
pBADVgrG4570-899VSV, pBADVgrG4570-899FLAG and pBADVgrG4612-759VSV. Correct
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insertion of the fragments was confirmed by PCR. The plasmids were then transformed into E.
coli β2163, and mobilized into K. pneumoniae strains by conjugation.
Isolation of secreted Hcp1
Bacteria containing pBADHcp1VSV were grown until mid-exponential phase in 15-ml plastic
tubes containing 5 ml of medium. Five millilitres of culture were centrifuged at 20,000 × g for
20 min and the supernatant was then filtered through a 0.2-μm filter. 450 μL of 100% trichloro-
acetic acid (TCA) solution were added to 4500 μL of the supernatant, and the sample was incu-
bated overnight at -20˚C. Proteins were recovered by centrifugation (15,000 × g for 10 min at
4˚C), and washed twice with ice cold acetone. The final precipitate was resuspended in 20 μL
of SDS sample buffer.
Immunoblotting
Proteins resolved by 15% SDS-PAGE and electroblotted onto nitrocellulose membranes.
Membranes were blocked with 4% bovine serum albumin (w/v) in PBS and protein bands
were detected with specific antibodies using chemiluminescence reagents and a G:BOX Chemi
XRQ chemiluminescence imager (Syngene). The following antibodies were used: anti-Flag
antibody (1:2,000; Sigma), anti-VSVG antibody (1:2,000; Sigma). Immunoreactive bands were
visualized by incubation with horseradish peroxidase-conjugated goat anti-rabbit immuno-
globulins (1:5000, BioRad 170–6515) or goat anti-mouse immunoglobulins (1:5000, BioRad
170–6516). To ensure that equal amounts of proteins were loaded, membranes were reprobed
after stripping of previously used antibodies using a pH 2.2 glycine-HCl/SDS buffer with anti-
E.coli RNA Polymerase α (1:2,000; BioLegend 663102).
GST fusions in yeast were immunodetected with primary rabbit polyclonal anti-GST (Z-5)
antibody (1:2000, Santa Cruz Biotechnology). Secondary antibodies were IRDye-680 or IRDye
-800 anti-rabbit and detection was performed with an Odyssey Infrared Imaging System
(LI-COR Biosciences).
Expression of vgrGs in S. cerevisiae
Yeast transformation was achieved by the standard lithium acetate protocol. Kp52145 vgrGs
were cloned into the 2μ-based pEG(KG) vector to express GST fusion proteins in yeast [93]
under the control of the GAL1 promoter. vgrG1, vgrG2 and vgrG4 were amplified by PCR
using primers carrying BamHI and XbaI restriction sites for vgrG1, and XbaI restriction sites
for vgrG2 and vgrG4 (S1 Table). All PCR products were cleaved with the corresponding
enzymes and inserted into the same site in the pEG(KG) vector and sequenced. vgrG4 trun-
cated variants were obtained by sit-directed mutagenesis using primers indicated in S1 Table.
S. cerevisiae strains expressing VgrGs were grown in Synthetic complete medium (SC) con-
taining 0.17% (w/v) yeast nitrogen base without amino acids, 0.5% (w/v) ammonium sulphate
and 2% (w/v) glucose, and was supplemented with appropriate amino acids and nucleic acid
bases. SCGal and SCRaf media were SC with 2% (w/v) galactose or raffinose, respectively,
instead of glucose. Galactose induction experiments in liquid media were performed by grow-
ing cells in SCRaf medium at 30 ºC to exponential phase and then adding galactose to 2% (w/
v) for 4–6 h. Effects of the expression of VgrG genes on yeast growth were tested by spotting
cells onto SC and SCGal plates lacking the corresponding auxotrophic marker to maintain the
plasmid. Briefly, transformants bearing pEG(KG)-based plasmids were grown overnight in SC
lacking uracil and leucine (SC–Ura-Leu) and adjusted to an OD600 of 0.5. This and three serial
1/10 dilutions were spotted on the surfaces of SC or SCGal solid media lacking uracil. Growth
was monitored after 2–3 days at 30ºC.
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Statistical analyses
Heat-maps were constructed using GraphPad Prism for Windows (version 5.03) software. Sta-
tistical analyses were performed using one-way ANOVA with Bonferroni correction for multi-
ple comparisons, or unpaired T-test. Survival analyses were undertaken using the Log-rank
(Mantel-Cox) test with Bonferroni correction for multiple comparisons (α = 0.008). All analy-
ses were performed using GraphPad Prism for Windows (version 5.03) software. P-values
of< 0.05 were considered statistically significant.
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in five K. pneumoniae strains: ATCC43816 (A), NTUH-K2044 (B), SGH1- (C), MGH78578
(D), NJST258_1 (E). Each loci is characterized by a distinct vgrG and a set of putative effector
(s) and immunity proteins. For each strain, additional t6ss related genes found elsewhere in
the genome are indicated.
In all panels, the colour code of the genes indicate putative structural genes (purple), hcp (dark
green), vgrG (red), effector (denoted as Kpe for K. pneumoniae effectors) (yellow), immunity
protein (denoted as Kpi for K. pneumoniae immunity protein) (orange), regulator (green), and
PAAR-domain containing protein (grey).
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S2 Fig. Lack of bacterial killing when K. pneumonaie 52.145 grows in LB. Recovery of E. coli
target cell following 6 h incubation with Kp52145, 52145-ΔmanC (ΔmanC), and S. marcescens
Db10 (Serratia). The data are presented as means ± the standard deviations (n = 3).����, results
are significantly different (P< 0.0001 [two-tailed t test]) from the results for PBS-treated
(mock) target cell.
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S3 Fig. Effect of growth phase on K. pneumoniae 52.145 T6SS expression. (A, B, C) Analysis
of the T6SS expression by Kp52145 carrying the transcriptional fusions tssB::lucFF to monitor
locus I, tssK2::lucFF to monitor locus II, and sciZ3::lucFF to monitor locus III. At the indicated
time points, an aliquot of the culture was taken to measure luciferase levels, and OD600. Lumi-
nescence is expressed as relative light units (RLU). The data are presented as means ± the stan-
dard deviations (n = 3).
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S4 Fig. Regulation of K. pneumoniae 52.145 T6SS loci II and III. Heat-map analysis of the
luciferase levels of the transcriptional fusion tssK2::lucFF (A) and sciZ3::lucFF (B) in the back-
ground of the wild-type strain grown until exponential phase at different temperatures
(Temp); pH, oxygen tension (1, 15-ml tube incubated vertically shaking at 180 rpm; 2, 15-ml
slanted tube (45o) shaking at 180 rpm; 3, 25-ml tube incubated vertically shaking at 180 rpm;
4, 30-ml tube incubated vertically shaking at 180 rpm), and different concentrations of KCl,
rhamnose, sucrose, NaCl and the iron chelator 2–2’ bipyridyl.
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S5 Fig. CPS does not affect K. pneumoniae T6SS activity. T6SS-dependent anti-bacterial
activity as determined by recovery of target organism E. coli MG1655 following 6 h co-incuba-
tion in LBpH6 (pH6), LBNaCl (NaCl (595 mM) with Kp52145, 52145-ΔclpV (ΔclpV), 52145-
ΔmanC (ΔmanC). The data are presented as means ± the standard deviations (n = 3). #,
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P< 0.0001; n.s. (P> 0.05) not significant differences from the results for mock-treated E. coli;
one-way ANOVA Bonferroni correction for multiple comparisons.
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S6 Fig. Identification of transcriptional factors controlling K. pneumoniae T6SS expres-
sion. (A, B) Analysis of the T6SS expression by Kp52145, 52145-Δhfq (hfq), 52145-ΔphoPQGB
(phoPQ), 52145-ΔpmrAB (pmrAB), 52145-Δfur (fur), 52145-Δhns (h-ns), 52145-ΔrpoS (rpoS),
52145-ΔrpoN (rpoN), 52145-ΔmgrB (mgrB), 52145-ΔmgrB-ΔphoPQGB (mgrB-phoPQ), 52145-
ΔrcsB (rcsB), and 52145-ΔrcsB-ΔphoPQGB (rcsB-phoPQ) carrying the transcriptional fusion
tssB::lucFF and grown in LBpH6 (pH6) and LBNaCl (NaCl 595 mM). The data are presented as
means ± the standard deviations (n = 3). #, results are significantly different (P < 0.0001) from
the results for Kp52145 and for the indicated comparison; ���, results are significantly different
(P< 0.001) from the results for Kp52145; n.s. results are not significantly different (P>0.05
001) from the results for Kp52145; one-way ANOVA Bonferroni correction for multiple com-
parisons.
(C, D) Bacterial killing activity mediated by Kp52145, 52145-Δhfq (hfq), 52145-ΔphoPQGB
(phoPQ), 52145-ΔpmrAB (pmrAB), 52145-Δfur (fur), 52145-Δhns (h-ns), 52145-ΔrpoS (rpoS),
52145-ΔrpoN (rpoN), 52145-ΔmgrB (mgrB), 52145-ΔmgrB-ΔphoPQGB (mgrB-phoPQ), 52145-
ΔrcsB (rcsB), and 52145-ΔrcsB-ΔphoPQGB (rcsB-phoPQ) against E. coli MG1655. Number of
recovered target cells following 6 h incubation in LBpH6 (pH6) and LBNaCl (NaCl 595 mM) is
indicated. The data are presented as means ± the standard deviations (n = 3). #, results are sig-
nificantly different (P< 0.0001) from the results for PBS-treated (mock) target cells; one-way
ANOVA Bonferroni correction for multiple comparisons.
(PDF)
S7 Fig. T6SS-mediated antibacterial competition is fuelled by T6SS active preys. (A, B, C)
T6SS-dependent anti-bacterial activity as determined by recovery of target organisms K. pneu-
moniae NTUH-K2044 (NTUH-K2044), A. baumannii DSM30011 (DSM30011) following
incubation with Kp52145, 52145-ΔclpV (ΔclpV), 52145-ΔphoPQGB (ΔphoPQ), and 52145-
ΔphoPQGBCom (ΔphoPQ::phoPQ). #, P< 0.0001; ��, P< 0.01; n.s (P> 0.05) not significant
differences from the results for PBS-treated (mock) target cell; one-way ANOVA Bonferroni
correction for multiple comparisons.
(C, D) T6SS-dependent anti-bacterial activity as determined by recovery of target t6ss mutants
NTUH-ΔtssB, DSM-ΔtssM following incubation with Kp52145. n.s., (P> 0.05) not significant
differences from the results for PBS-treated (mock) target cell.
In all panels, the data are presented as means ± the standard deviations (n = 3).
(PDF)
S8 Fig. T6SS-dependent antagonism against E. coli prey. (A, B, C) T6SS-dependent anti-bac-
terial activity as determined by recovery of target organisms E. coli MG1655 following incuba-
tion with K. pneumoniae ATCC43816 (Kp43816), 43816-ΔtssB (43816-ΔtssB), K. pneumoniae
NTUH-K2044 (NTUH), NTUH-ΔtssB (NTUH-ΔtssB), A. baumannii ATCC17978 (17978),
17978-ΔtssM (17978-ΔtssM), A. baumannii DSM30011 (DSM), A. baumannii DSM30011-
ΔtssM, (DSM30011-ΔtssM), B. cenocepacia K56-2 (K56-2), and K56-2-ΔatsRΔT6SS (ΔT6SS) in
LB. #, results are significantly different (P< 0.0001 [one-way ANOVA Bonferroni for multiple
comparisons]) for the indicated comparisons. Mock, PBS-treated target cell. The data are pre-
sented as means ± the standard deviations (n = 3).
(PDF)
S9 Fig. Co-incubation with bacteria with an active T6SS upregulates K. pneumoniae T6SS
in a PhoPQ-dependent manner. (A, B, C) Expression of T6SS by Kp52145, 52145-ΔphoPQGB
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(ΔphoPQ), and 52145-ΔphoPQGBCom (ΔphoPQ::phoPQ) carrying the transcriptional fusion
tssB::lucFF after co-incubation with K. pneumoniae ATCC43816 (Kp43186), K. pneumoniae
NTUH-K2044 (NTUH-K2044), A. baumannii ATCC17978 (17978), and B. cenocepacia K56-2
(K56-2). #, results are significantly different (P< 0.0001 [one-way ANOVA Bonferroni for
multiple comparisons]) from the results for PBS-treated (mock) Kp52145. In all panels, lumi-
nescence is expressed relative light units (RLU) per CFU (x109). The data are presented as
means ± the standard deviations (n = 3).
(PDF)
S10 Fig. The periplasmic domain of PhoQ is needed for the regulation of the T6SS. (A, B,
C) Expression of T6SS by Kp52145, 52145-ΔphoPQGB (ΔphoPQ), 52145-ΔphoQGBComFLAG
(ΔphoPQ::phoPQFLAG), 52145-ΔphoQGBComPhoQ45-190 (ΔphoPQ::phoPQ45-190), and 52145-
ΔphoQGBComPhoQGNNNNAQ (ΔphoPQ::phoPQGNNNNAQ) carrying the transcriptional fusion
tssB::lucFF after incubation in LB, LBpH6 (pH6), and LBNaCl (NaCl 595 mm). #, results are sig-
nificantly different (P< 0.0001 [one-way ANOVA Bonferroni for multiple comparisons]) for
the indicated comparisons.
(D) Western blot analysis using an anti-FLAG antibody demonstrating the presence of PhoQ
in cell pellets of 52145-ΔphoQGBComFLAG (phoQ), 52145-ΔphoQGBComPhoQ45-190
(phoQ45-190), and 52145-ΔphoQGBComPhoQGNNNNAQ (phoQGNNNNAQ). Membranes were
reprobed with antibody anti RNA Polymerase α. Images are representative of three indepen-
dent experiments.
(PDF)
S11 Fig. Role of K. pneumoniae T6SS VgrGs in bacterial competition. (A, B, C) T6SS-depen-
dent anti-bacterial activity as determined by recovery of target organism E. coli MG1655 fol-
lowing incubation with Kp52145, 52145-ΔclpV (ΔclpV), 52145-ΔvgrG1 (ΔvgrG1), 52145-
ΔvgrG1 harbouring pBADVgrG1 (ΔvgrG1/ pBADVgrG1), 52145-ΔvgrG2 (ΔvgrG2), 52145-
ΔvgrG4 (ΔvgrG4), 52145-ΔvgrG4 harbouring pBADVgrG4 (ΔvgrG4/pBADVgrG4), 52145-
ΔvgrG2-ΔvgrG1 (ΔvgrG2-ΔvgrG1), 52145-ΔvgrG1-ΔvgrG4 (ΔvgrG1-ΔvgrG4), 52145-ΔvgrG2-
ΔvgrG4 (ΔvgrG2-ΔvgrG4), 52145-ΔvgrG2- ΔvgrG1-ΔvgrG4 (ΔvgrG2- ΔvgrG1-ΔvgrG4) in LBpH6
(pH6), LBNaCl (NaCl 595 mM), and with sublethal concentration of colistin (0.1 μg/ml) in LB.
In all panels, #, P< 0.0001; n.s. (P> 0.05), not significant differences from the results for PBS-
treated (mock) target cell; one-way ANOVA Bonferroni for multiple comparisons. The data
are presented as means ± the standard deviations (n = 3).
(PDF)
S12 Fig. K. pneumoniae T6SS mutants displayed reduced virulence in the G. mellonella
infection model. Kaplan–Meier plots showing the per cent survival of G. mellonella over 120 h
post-infection with 105 organisms of the following strains: K. pneumoniae NTUH-K2044
(NTHU-K2044), NTHU-ΔtssB, K. pneumoniae ATCC43816 (Kp43816), 43816-(ΔtssB), or
PBS. Thirty larvae were infected in each group. Level of significance was determined using the
log-rank (Mantel–Cox) test with Bonferroni correction for multiple comparisons where appli-
cable [a = (A) 0.0008; (B) 0.05]. ����, P< 0.0001, ���, P < 0.001 for the indicated comparisons.
(PDF)
S13 Fig. Growth kinetics of K. pneumoniae T6SS mutants. Growth kinetics of K. pneumo-
niae 51245 (Kp52145), 52145-ΔclpV (ΔclpV), 52145-ΔvgrG1 (ΔvgrG1), 52145-ΔvgrG2
(ΔvgrG2), 52145-ΔvgrG4 (ΔvgrG4), 52145-ΔvgrG2-ΔvgrG1 (ΔvgrG2-ΔvgrG1), 52145-ΔvgrG1-
ΔvgrG4 (ΔvgrG1-ΔvgrG4), 52145-ΔvgrG2-ΔvgrG4 (ΔvgrG2-ΔvgrG4), 52145-ΔvgrG2- ΔvgrG1-
ΔvgrG4 (ΔvgrG2- ΔvgrG1-ΔvgrG4) in LB broth (LB) (A) and 2% glucose M9 minimal media
supplemented with thiamine and MgSO4 (M9-0.2% glucose) (B) over 24 h at 37˚C. Values are
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presented as the mean ± SD of three independent experiments measured in triplicate.
(PDF)
S14 Fig. Expression of VgrGs and truncated variants in E. coli. Western blot analysis using
anti-FLAG (A, B) and anti-VSV-G (C) antibodies demonstrating the presence of VgrG1,
VgrG2, VgrG4, VgrG41-517, VgrG4570-899, VgrG4612-759, VgrG1603-750 in the cell lysates of E.
coli. Membranes were reprobed with antibody anti RNA Polymerase α. Images are representa-
tive of three independent experiments.
(PDF)
S15 Fig. VgrG4 is a trans-kingdom effector of K. pneumoniae T6SS. (A) Growth on SD (glu-
cose) and SG (galactose) plates at 30˚C and 37˚C of serial dilutions of wild-type YPH499 yeast
cells harbouring plasmids encoding the indicated vgrGs, and therefore expressing the corre-
sponding proteins under the control of the GAL1 promoter on galactose-based medium.
Image is representative of three independent experiments.
(B) Immunoblot analysis of the expression of each of the VgrG4 variants in yeast using anti-
GST antibody.
(PDF)
S16 Fig. VgrG4 toxic effect is ROS-dependent. (A) ROS levels in E. coli harbouring the indi-
cated plasmids following induction of the Ara promoter of the pBAD plasmid with arabinose
(0.1%) for 60 min by assessing the fluorescence of the dye CM-H2DCFDA. When indicated,
ascorbate (15 mM) was added to supplement LB determined. Results are expressed in relative
fluorescence units (RFU), and presented as means ± the standard deviations (n = 3). #, results
are significantly different (P< 0.0001 [two-tailed t test]) from the results for bacteria harbour-
ing pBAD30.
(B) Single-cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA in
E. coli harbouring pBADVgrG4570-699 pMMBSel1E following induction with arabinose and
IPTG for 60 min. Hoechst was used to stain bacterial DNA. Images are representative of three
independent experiments. When indicated, ascorbate (15 mM) was added to supplement the
culture media.
(C) Single-cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA in
E. coli harbouring pBADVgrG4612-759 pMMBSel1E following induction with arabinose and
IPTG for 60 min. Hoechst was used to stain bacterial DNA. Images are representative of three
independent experiments. When indicated, ascorbate (15 mM) was added to supplement the
culture media.
(D) Single-cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA in
E. coli upon co-cultivation with Kp52145, 52145-ΔclpV (ΔclpV), 52145-ΔvgrG4 (ΔvgrG4),
52145-ΔvgrG4 harbouring pBADVgrG4 (ΔvgrG4/ pBADVgrG4). Hoechst was used to stain
bacterial DNA. Images are representative of three independent experiments.
(E) Single-cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA in
E. coli harbouring pMMBSel1E upon co-cultivation with Kp52145 following induction with
IPTG for 60 min. Hoechst was used to stain bacterial DNA. Images are representative of three
independent experiments.
(PDF)
S17 Fig. Sel1E abolishes VgrG4-induced ROS responses. A) Sel1E is not a general ROS scav-
enger. Single-cell analysis of ROS using the general ROS fluorescence sensor CM-H2DCFDA
in E. coli harbouring pMMBSel1E upon incubation with ethanol (20%) following induction
with IPTG for 60 min. Hoechst was used to stain bacterial DNA. Images are representative of
three independent experiments.
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(B) soxS, oxyS, oxyR, and kat levels assessed by RT-qPCR in E. coli harbouring the indicated
plasmids following induction of the Ara promoter of the pBAD plasmid with arabinose
(0.1%), and the tac promoter of the pMMB207 plasmid with IPTG (1 mM) for 60 min. The
data are presented as means ± the standard deviations (n = 3).
(PDF)
S1 Data. Analysis of the T6SS effectors from 700 K. pneumonaie genomes against the
SecRet6 effector database.
(CSV)
S2 Data. Analysis of the T6SS core components from 700 K. pneumonaie genomes against
the SecRet6 core component database.
(CSV)
S3 Data. Phylogenetic tree of 700 K. pneumoniae genomes.
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